Attached files

file filename
EX-10.2 - EXHIBIT 10.2 - ANTS SOFTWARE INCa6259567ex10-2.htm
EX-23.1 - EXHIBIT 23.1 - ANTS SOFTWARE INCa6259567ex23-1.htm
EX-10.1 - EXHIBIT 10.1 - ANTS SOFTWARE INCa6259567ex10-1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM S-1
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

ANTS SOFTWARE INC.
(Exact name of registrant as specified in its charter)
Delaware
 
7371
 
13-3054685
(State or other jurisdiction of
 
(Primary Standard Industrial
 
(I.R.S. Employer
incorporation or organization)
 
Classification Code Number)
 
Identification Number)

71 Stevenson Street, Suite 400
San Francisco, CA 94105
(650) 931-0500
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)


David Buckel
Chief Financial Officer
71 Stevenson Street, Suite 400
San Francisco, CA 94105
 (650) 931-0500
(Name, address, including zip code, and telephone number, including area code, of agent for service)

 
Copies to:
Paul David Marotta
Megan Jeanne
The Corporate Law Group
500 Airport Blvd., Suite 120
Burlingame, CA 94010

Approximate Date of Commencement of Proposed Sale to the Public:  From time to time after the effective date of this Registration Statement as determined by market conditions and other factors.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box:  [X]

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  
 
 
 

 

 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer  [  ]                                                                                                Accelerated filer  [  ]

Non-accelerated filer  [  ]                                                                                                Smaller reporting company  [X]

 
Calculation of Registration Fee

Title of Each Class of
Securities to Be
Registered
Amount to Be
Registered
Proposed
Maximum
Offering Price Per
Unit
Proposed Maximum
Aggregate Offering
Price
Amount of
Registration
Fee
(4)
Common Stock, par value $0.0001
1,500,000 shares(1)
$1.00
$1,500,000
$107
Common Stock, par value $0.0001
25,109,536 shares(2)
$0.865(3)
$21,719,751
$1,549
 
 
 
(1)
1,500,000 shares of common stock previously sold to selling security holder in a private placement transaction under the purchase agreement.
 
(2)
Additional shares of common stock which may be sold to the selling security holder under the purchase agreement and accompanying warrants.
 
(3)
Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended (the “Securities Act”), based upon the price per share of $0.865 which was the average of the high and low sales price per share of our common stock as reported on the Over-the-Counter Bulletin Board on April 20, 2010.
 
(4)
Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.

The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
 
 
 

 
 
 
The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

Preliminary Prospectus, Subject to Completion dated April 20, 2010
 
PROSPECTUS
 
Logo
 
26,609,536 Shares of Common Stock
 
 
This prospectus relates to the issuance and resale of up to 26,609,536 shares of our common stock to be offered by the selling security holder, consisting of (a) 25,109,536 unissued shares of our common stock to be offered for resale by the selling security holder upon (i) the exercise of a warrant to purchase up to 11,074,197 shares of common stock, and (ii) the issuance of up to 14,035,339 shares pursuant to the terms and conditions of a certain stock purchase agreement, and (b) 1,500,000 currently issued shares of our common stock to be offered for resale by the selling security holder.
        
We will not receive any of the proceeds from the sale of the shares by the selling security holder.  We have and will continue to bear the costs relating to the registration of these shares.  We should receive proceeds from the issuance of the shares pursuant to the terms and conditions of the Stock Purchase Agreement, if any, although we may not receive any proceeds from the exercise of the warrants by the selling security holder.  We intend to use any proceeds received by us for general corporate purposes.  
        
The selling security holder, or its pledgees, donees, transferees or other successors-in-interest, may offer the shares from time to time through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices.  See “Plan of Distribution” which begins on page 14.

Our common stock is quoted on the Over-the-Counter Bulletin Board under the symbol "ANTS" On April 20, 2010, the closing sale price of our common stock on the Over-the-Counter-Bulletin-Board was $0.89 per share.  You are urged to obtain current market quotations for the common stock.

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements carefully before you invest.

Investment in our common stock involves risks. See "Risk Factors" beginning on page 5 of this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.


The date of this prospectus is April 20, 2010
 
 
i

 
 
TABLE OF CONTENTS
 
Part I
 
1
   
3
   
4
   
Summary Financial and Operating Information 5
   
5
   
11
   
11
   
11
   
12
   
14
   
16
   
17
   
18
   
18
   
22
   
22
   
23
   
Dividend Policy 24
   
24
   
24
   
24
   
24
   
24
   
24
   
24
   
26
   
27
   
27
   
27
   
28
   
Part II
   
30
   
30
   
31
   
33
   
34
   
36
 
 
 
ii
 

 
If it is against the law in any state to make an offer to sell these shares, or to solicit an offer from someone to buy these shares, then this prospectus does not apply to any person in that state, and no offer or solicitation is made by this prospectus to any such person.  Brokers or dealers effecting transactions in the securities should confirm the registration of these securities under the securities laws of the states in which transactions occur or the existence of our exemption from registration.

You should rely only on the information contained in this prospectus.  We have not authorized anyone to provide you with different information.  If anyone provides you with different or inconsistent information, you should not rely on it.  We are not making an offer to sell these securities in any jurisdiction where the offer and sale is not permitted.  You should assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus.  Our business, financial condition, results of operations and prospects may have changed since that date.
 
 
iii

 



This summary highlights certain information appearing elsewhere in this prospectus.  For a more complete understanding of this offering, you should read the entire prospectus carefully, including the risk factors and the financial statements.  References in this prospectus to "we," "our", "us," “ANTs” and the “Company” refer to ANTs software inc., except as otherwise indicated or as the context otherwise requires.

Company Business Overview

The Company

We have developed a software solution, the ANTs Compatibility Server (“ACS”), to allow customers to move software applications from one database product to another without time consuming and costly database migrations and application rewrites.  ACS translates the languages used by database products so that software applications written for one database product will work with another.  ACS allows customers to replace the database product without replacing the software application. Our first ACS product translates Sybase’s database product to run on Oracle’s database product. We are in the process of developing additional ACS products that will translate additional database languages.

In May 2008, ANTs acquired Inventa Technologies Inc. (“Inventa”) of Mt. Laurel, New Jersey.  Inventa is a wholly-owned subsidiary that manages and optimizes applications and databases for large enterprises and provides installation and support services for the ACS (together, “Professional Services”).

Our headquarters are located in San Francisco, California and we have offices in Mt. Laurel, New Jersey and Alpharetta, Georgia.  We have financed operations through private offerings to accredited investors and asset managers to whom we have sold common stock and issued convertible promissory notes and warrants.  We expect to continue to raise capital for operations through such private offerings until we generate positive cash flows from operations.  We believe we have sufficient funds to cover operations into the fourth quarter of 2010 at our expected expense rate.  We expect that our focus over the next year will be on the continued development, marketing and sales of ACS and on the growth of our Professional Services offerings.

The ANTs Compatibility ServerTM

Applications written to work with one database product are typically incompatible with other database products due to proprietary extensions developed and popularized by the database vendors.  This has the effect of locking customers into one database vendor because it would generally be cost-prohibitive and too time-consuming to migrate an application from one database to another.  ACS translates these proprietary extensions from one database product to another and allows customers to migrate applications from one database product to another more easily and at less cost.

We have developed the underlying technologies related to ACS with the first version of ACS allowing applications currently running on Sybase's database product to run on Oracle's database product.  During 2008, ANTs completed pilots for an early group of customers and in December 2008 announced its first commercial deployment with the Wyndham Hotel Group call center application. In the future, we expect to build versions of ACS that will enable applications to be migrated from and to numerous other database products.

Professional Services

Established in 1993, Inventa, our IT managed services and professional services division, provides pre- and post-sales services related to the ACS and application migration, application and database architecting, monitoring and management.  We provide Professional Services to customers in the hospitality, banking, insurance, gaming, automotive and high-technology industries.  We have extensive experience in architecting enterprise application and database deployments, upgrades and migrations and in installing, configuring, deploying and maintaining database products from major vendors such as IBM, Oracle, Microsoft and Sybase.  We have developed proprietary software that enables us to remotely monitor, diagnose and maintain customer applications and databases, saving customers the cost of having to maintain in-house IT resources needed to deliver these services.
 
 
1

 

Industry Background
 
The Market

According to IDC Research, the market for database products was $20 billion in 2008.   Oracle, Microsoft and IBM control approximately 83% of this market.  According to the numerous Chief Technology Officers, database architects and application developers at the target Global 2000 enterprises with whom we have spoken, database infrastructure costs have become one of the most expensive line items in the IT budget.  These Global 2000 enterprises typically have annual database "spends" in excess of tens and, in some cases, hundreds of millions of dollars and their database budgets are growing annually.  The migration cost from one database to another, even to a low-cost open-source database, is extensive due to lack of compatibility between the products' proprietary extensions.  There is significant interest, confirmed by our discussions with industry analysts and user groups, for a product that can provide the capability to migrate an application from one database to another.

Also according to IDC Research, the markets in which our Professional Services group operates, IT services and application management, were $122 billion in 2007 with IBM Global Services, HP/EDS and Accenture being among the largest vendors in those markets.  We have a unique combination of experience, skills and proprietary software that allow us to address a segment of the IT services market centered on database and application monitoring, maintenance and services.  In addition to this established market, we anticipate that our Professional Services group will be the first provider of migration and consulting services resulting from pre- and post-sales of our ACS products.  We expect our ACS customers will look to us as the experts in database consolidation to provide a full range of services related to ACS installation, deployment and use.  To the extent that this becomes a new "market" for Professional Services, we are in a position to capitalize on it.

Our Strategy

Our go-to-market strategy adapts with changes in the competitive structure of the database market.  The refinement of our strategy is a continuous and iterative process, reflecting our goal of providing a cost-effective solution across a wide variety of applications.  Our strategy has recently included:
 
 
·
Developing partnerships with IBM, Oracle, Microsoft, Sybase and others to bring our products to market;
 
 
·
Focusing on large enterprise customers who can realize significant savings by migrating applications among leading database products;
 
 
·
Selling or licensing our products directly;
 
 
·
Selling our products and technologies through partners; and
 
 
·
Developing custom versions of our products for our partners and selling or licensing that technology to them.
 

ACS can provide a solution for enterprises to address the problems of vendor lock-in and cost escalation by enabling them to migrate applications among database products.  ACS can provide a potentially significant competitive advantage for database vendors such as Oracle, IBM, Microsoft, Sybase and others because they would have the ability to cost-effectively migrate applications from their competitors’ products to their own.

In August 2009, the Company announced that negotiations had been completed regarding the supply of database migration technology to a Global IT vendor.  An Original Equipment Manufacturer agreement (“OEM Agreement”) has been completed and signed by both parties.  Confidentiality provisions of the OEM Agreement preclude the naming of the vendor until approved by both parties.  The Company anticipates substantial business and future revenue to be generated from this agreement.  According to the OEM Agreement, ANTs is responsible for technology development specifically tailored to the Global IT vendor needs.  The Global IT vendor will assume responsibility for marketing, sales and support of the technology on a worldwide basis, while ANTs will be the preferred service provider for migration projects.
 
 
2

 

Competition

We have not identified a direct competitor for our ACS database migration products.  Other database vendors encourage migration from competitive products through use of their proprietary migration tools.  These tools often require substantial investment to rewrite applications.  Potential customers with whom we have spoken are not receptive to these migrating applications due to the expense and risk of such rewrites.  While database vendors do not offer a directly competitive product, we fully expect database vendors to offer incentives for customers to keep applications deployed on their database products.

Competitors in the Professional Services market are large and well-established, with vendors such as IBM Global Services, HP/EDS and Accenture offering a wide range of services.  We have maintained long-term relationships with our customers and have been successful in renewing contracts and in signing multi-year contracts.

Risks That We Face
 
Our business is subject to a number of risks that you should understand before making an investment decision. These risks are discussed more fully in the “Risk Factors” section of this prospectus and include but are not limited to the following:

 
·
We have a history of losses and a large accumulated deficit and we may not be able to achieve profitability in the future.

 
·
We may be unable to successfully execute any of our identified business opportunities that we determine to pursue.

 
·
We may incur substantial penalties or lose a potential source of significant funding if we are unable to have this Registration Statement declared effective by the United States Securities and Exchange Commission (“SEC”) by July 1, 2010.

 
·
We depend on a limited number of customers for a significant portion of our revenue.

 
·
If we are unable to protect our intellectual property, our competitive position would be adversely affected.

 
·
If we experience rapid growth, we will need to manage such growth well.

 
·
Market acceptance of our products and services is not guaranteed and our business model is evolving.

 
·
Our ANTs Compatibility Server (“ACS”) product is at an early stage and our business model is not well established.

 
·
We will need to continue our product development efforts.

 
·
We face rapid technological change.

 
·
A failure to obtain financing could prevent us from executing our business plan or operate as a going concern.


The Company’s headquarters are located at 71 Stevenson Street, Suite 400, San Francisco, CA 94105; (650) 931-0500.
 
 
3

 

About This Offering

On March 12, 2010, we entered into a stock purchase agreement (“Stock Purchase Agreement”) with Fletcher International, Ltd. (“Fletcher”), an affiliate of Fletcher Asset Management, Inc.  In connection with the Stock Purchase Agreement, Fletcher agreed to invest up to $10,000,000 in ANTs through purchase of shares of common stock at various prices conditioned on satisfaction of certain conditions in the Stock Purchase Agreement.  Fletcher also holds a warrant to purchase up to an additional $10,000,000 of ANTs common stock and, depending on satisfaction of certain subsequent conditions, may be issued a subsequent warrant to purchase up to an additional $10,000,000 of ANTs common stock.  As of the date of this prospectus, 1,500,000 shares of common stock have been issued to Fletcher in connection with Fletcher’s initial investment under the Stock Purchase Agreement, and up to 25,109,536 additional shares are reserved for future issuance to Fletcher pursuant to the terms and conditions of the Stock Purchase Agreement and accompanying warrants.

This prospectus relates to the issuance and resale of up to 26,609,536 shares of our common stock to be offered by the selling security holder, consisting of (a) 25,109,536 unissued shares of our common stock to be offered for resale by the selling security holder upon (i) the exercise of a warrant to purchase up to 11,074,197 shares of common stock, and (ii) the issuance of up to 14,035,339 shares pursuant to the terms and conditions of the Stock Purchase Agreement and accompanying warrants, and (b) 1,500,000 currently issued shares of our common stock to be offered for resale by the selling security holder.


The following table is a summary of the shares being offered by the selling security holder pursuant to this prospectus:

Common Stock Offered by Selling Security Holder
Up to 26,609,536 shares of Common Stock (including 1,500,000 shares of common stock already issued to Fletcher and 11,074,197 shares of common stock issuable upon exercise of the currently-held warrant).
   
Common Stock Outstanding Prior to the Offering
107,236,988 shares as of March 31, 2010
   
Common Stock Outstanding After the Offering
132,346,524 shares (assuming full subscription of all common shares reserved for selling security holder)
   
Use of Proceeds
We will not receive any proceeds from the resale of the shares of common stock by the selling security holder.  However, with respect to shares of common stock issuable upon exercise of an outstanding warrant held by the selling security holder and a potential future warrant to selling security holder, we may receive up to approximately $20,000,000 if all of the outstanding warrants are exercised, unless the selling security holder elects to exercise warrants pursuant to the cashless exercise provisions of the warrants.  To the extent the warrants are exercised pursuant to the cashless exercise provisions, we will not receive any proceeds from the exercise of the warrants.  Any proceeds we receive from the exercise of outstanding warrants by the selling security holder will be used for general corporate purposes, which may include working capital, capital expenditures, development costs, strategic investments and possible acquisitions.
   
Over-the-Counter Trading Symbol
ANTS
   
Risk Factors
The Securities offered hereby involve a high degree of risk.  See the Section entitled RISK FACTORS on page 5 for a discussion of the risk and certain additional factors that should be considered in evaluating an investment in the common stock.
 
 
4

 
 

The following summary financial information is derived from and should be read in conjunction with the Company’s Financial Statements, including the notes thereto, incorporated herein by reference to the Company’s Annual Report for the fiscal year ended December 31, 2009 on Form 10-K filed with the SEC on March 31, 2010, as amended on Form 10-K/A filed with the SEC on April 21, 2010.

Summary of Operations

For the Years Ended December 31,
 
   
2009
   
2008
 
Total revenue
 
$
5,811,682
   
$
8,282,729
 
Loss from operations
 
$
(8,346,296)
   
$
(8,455,180)
 
Net loss applicable to common stockholders
 
$
(25,309,688)
   
$
(11,628,584)
 
Net loss per common share (basic and diluted)
 
$
(0.27)
   
$
(0.15)
 
Weighted average common shares outstanding
   
95,026,487
     
77,847,729
 


As of December 31,
   
2009
   
2008
 
Cash and cash equivalents
 
$
1,168,024
   
$
2,051,807
 
Total assets
 
$
30,269,857
   
$
33,456,805
 
Working capital (deficiency)
 
$
(132,940)
   
$
2,358,848
 
Long term debt
 
$
1,286,209
   
$
2,703,260
 
Stockholders’ equity
 
$
26,069,527
   
$
28,043,297
 

 

Special Note Regarding Forward-Looking Statements

This Prospectus and the information incorporated herein by reference contain forward-looking statements that involve a number of risks and uncertainties, as well as assumptions that, if they never materialize or if they prove incorrect, would likely cause our results to differ materially from those expressed or implied by such forward-looking statements.  Although our forward-looking statements reflect the good faith judgment of our management, these statements can only be based on facts and factors currently known by us.  Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from results and outcomes discussed in the forward-looking statements.

Forward-looking statements can be identified by the use of forward-looking words such as “believes,” “expects,” “hopes,” “may,” “will,” “plans,” “intends,” “estimates,” “could,” “should,” “would,” “continue,” “seeks” or “anticipates,” or other similar words (including their use in the negative), or by discussions of future matters such as the development of new products, problems incurred in establishing sales and sales channels, technology enhancements, possible changes in legislation and other statements that are not historical.  These statements include, but are not limited to, statements under the captions “Company Business Overview,” and “Risk Factors,” as well as other sections in this prospectus.  You should be aware that the occurrence of any of the events discussed under the heading Risk Factors and elsewhere in this prospectus could substantially harm our business, results of operations and financial condition.  If any of these events occurs, the trading price of our common stock could decline and you could lose all or a part of the value of your shares of our common stock.
 
 
5

 
  
The cautionary statements made in this prospectus are intended to be applicable to all related forward-looking statements wherever they may appear in this prospectus.  We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this prospectus.

In addition to other information in this prospectus, the following risk factors should be carefully considered in evaluating our business since it operates in a highly changing and complex business environment that involves numerous risks, some of which are beyond our control.  The following discussion highlights a few of these risk factors, any one of which may have a significant adverse impact on our business, operating results and financial condition.  As a result of the risk factors set forth below and elsewhere in this prospectus, and the risks discussed in our other SEC filings, actual results could differ materially from those projected in any forward-looking statements.

We face significant risks, and the risks described below may not be the only risks we face.  Additional risks that we do not know of or that we currently consider immaterial may also impair our business operations.  If any of the events or circumstances described in the following risks actually occurs, our business, financial condition, results of operations or any combination thereof could be harmed and the trading price of our common stock could decline.
 
Economic Risks

The fragile state of the worldwide economy could impact the Company in numerous ways.  The effects of the  ongoing worldwide economic crisis has caused disruptions and extreme volatility in global financial markets, increased rates of default and bankruptcy, has impacted levels of consumer spending, and may impact our business, operating results, financial condition or any combination thereof.  The ongoing worldwide economic crisis, supply weakness in the credit markets and significant liquidity problems for the financial services industry may also impact our financial condition in a number of ways.   We might face increased problems in collecting our trade receivables, notes, and other obligations receivable. Since we rely on those receivables to finance our ongoing business operations, failure to collect our receivables might cause our business and operations to be severely and materially adversely affected.  Also, we may have difficulties in securing additional financing.
 
Business Risks

We have a history of losses and a large accumulated deficit and we may not be able to achieve profitability in the future.

For the years ended December 31, 2009 and 2008 we incurred net losses of $25,309,688 and $11,628,584, respectively.  Our accumulated deficit totals $113,239,302 at December 31, 2009.  There can be no assurance that we will be profitable in the future.  If we are not profitable and cannot obtain sufficient capital, we may have to cease our operations.

We may be unable to successfully execute any of our identified business opportunities that we determine to pursue.

We currently have a limited corporate infrastructure.  In order to pursue business opportunities, we will need to continue to build our infrastructure and operational capabilities.  Our ability to do any of these successfully could be affected by any one or more of the following factors:
 
 
·
Our ability to raise substantial additional capital to fund the implementation of our business plan;
 
 
·
Our ability to execute our business strategy;
 
 
·
The ability of our current or potential future products and services to achieve market acceptance;
 
 
·
Our ability to manage the expansion of our operations and any acquisitions that we may make, which could result in increased costs, high employee turnover or damage to customer relationships;
 
 
6

 
 
 
·
Our ability to attract and retain qualified personnel;
 
 
·
Our ability to manage our third party relationships effectively; and
 
 
·
Our ability to accurately predict and respond to rapid technological changes in our industry and the evolving demands of the markets we serve.

Our failure to adequately address any one or more of the above factors could have a significant adverse effect on our ability to implement our business plan and our ability to pursue other opportunities that arise.

We may incur substantial penalties or lose a potential source of significant funding if we are unable to have the registration statement declared effective by the SEC by July 1, 2010.

On March 12, 2010, we entered into a stock purchase agreement with Fletcher International, Ltd. (“Fletcher”) whereby Fletcher would invest in the Company through purchase of shares of our common stock and potential future exercise of warrants to purchase shares of common stock.  Under the terms of the agreement, we are required to register the shares issued and reserved for future issuance through a registration statement which is required to become effective on or before July 1, 2010.  We begin to incur penalties for each day after July 1, 2010 in which the registration statement is not effective and those penalties could become substantial within a relatively short time after July 1, 2010.  In addition, failure to have the registration statement declared effective by July 1, 2010 could result in Fletcher no longer being obligated to purchase our shares of common stock.

We rely on key personnel and, if we are unable to retain or motivate key personnel or hire qualified personnel, we may not able to grow effectively.

Our success depends in large part upon the abilities and continued service of our executive officers, including Joseph Kozak, our Chief Executive Officer, and David Buckel, our recently hired Chief Financial Officer, and other key employees.  There can be no assurance that we will be able to retain the services of such officers and employees. Our failure to retain the services of our key personnel could have a material adverse effect on us.  In order to support our projected growth, we will be required to effectively recruit, hire, train and retain additional qualified management personnel.  Our inability to attract and retain the necessary personnel could have a material adverse affect on us.

We depend on a limited number of customers for a significant portion of our revenue.

During 2009 our three largest customers accounted for approximately 97% of our revenue.  Revenue from one of these customers was $3.9 million, or 66% of total revenues.  Revenues from the second and third customers were $1.4 million, or 25% of total revenues, and $369,000 or 6% of total revenues, respectively.  A decrease in revenue from any of our largest customers for any reason, including a decrease in pricing or activity, or a decision to either utilize another vendor or to no longer use some or all of the products and services we provide, could have a material adverse affect on our revenue.

We rely upon reselling partners and independent software vendors for product sales.

A significant portion of our sales has been, and we believe will continue to be, made through reselling partners and independent software vendors (together "Partners").  As a result, our success may depend on the continued sales efforts of Partners, and identifying and entering into agreements with additional Partners.  The use of Partners involves certain risks, including risks that they will not effectively sell or support our products, that they will be unable to satisfy their financial obligations with us, and that they will cease operations.  Any reduction, delay or loss of orders from Partners may harm our results.  There can be no assurance that we will identify or engage qualified Partners in a timely manner, and the failure to do so could have a material adverse affect on our business, financial condition and results of operations.
 
 
7

 

If we are unable to protect our intellectual property, our competitive position would be adversely affected.

We rely on patent protection, as well as trademark and copyright law, trade secret protection and confidentiality agreements with our employees and others to protect our intellectual property.  Despite our precautions, unauthorized third parties may copy our products and services or reverse engineer or obtain and use information that we regard as proprietary.  We have filed one patent application with the United States Patent and Trademark Office for our ACS product and intend to file more.  No patents have been granted for our ACS product.  One trademark has been granted.  In addition, the laws of some foreign countries do not protect proprietary rights to the same extent as do the laws of the United States.  Our means of protecting our proprietary rights may not be adequate and third parties may infringe or misappropriate our patents, copyrights, trademarks and similar proprietary rights.  If we fail to protect our intellectual property and proprietary rights, our business, financial condition and results of operations would suffer.  We believe that we do not infringe upon the proprietary rights of any third party, and no third party has asserted an infringement claim against us.  It is possible, however, that such a claim might be asserted successfully against us in the future.  We may be forced to suspend our operations to pay significant amounts to defend our rights, and a substantial amount of the attention of our management may be diverted from our ongoing business, all of which would materially adversely affect our business.

If we experience rapid growth, we will need to manage such growth well.

We may experience substantial growth in the size of our staff and the scope of our operations, resulting in increased responsibilities for management.  To manage this possible growth effectively, we will need to continue to improve our operational, financial and management information systems, will possibly need to create departments that do not now exist, and hire, train, motivate and manage a growing number of staff.  Due to a competitive employment environment for qualified technical, marketing and sales personnel, we expect to experience difficulty in filling our needs for qualified personnel.  There can be no assurance that we will be able to effectively achieve or manage any future growth, and our failure to do so could delay product development cycles and market penetration or otherwise have a material adverse effect on our financial condition and results of operations.

We could face information and product liability risks and may not have adequate insurance.

Our products may be used to manage data from critical business applications.  We may become the subject of litigation alleging that our products were ineffective or disruptive in their treatment of data, or in the compilation, processing or manipulation of critical business information.  Thus, we may become the target of lawsuits from injured or disgruntled businesses or other users.  We carry product and information liability and errors and omissions insurance, but in the event that we are required to defend more than a few such actions, or in the event our products are found liable in connection with such an action, our business and operations may be severely and materially adversely affected.

We have indemnified our officers and directors.

We have indemnified our Officers and Directors against possible monetary liability to the maximum extent permitted under Delaware law.

Market acceptance of our products and services is not guaranteed and our business model is evolving.

We are at an early stage of development and our revenue will depend upon market acceptance and utilization of our products and services, including ACS which is now under development.  Our products are under constant development and are still maturing.  Customers may be reluctant to purchase products from us because they may be concerned about our financial viability and our ability to provide a full range of support services.  Given these risks, customers may only be willing to purchase our products through partners who are not faced with similar challenges. We may have difficulty finding partners to resell our products.  Also, due to current economic conditions, including the current recession, some potential customers may have tightened budgets for evaluating new products and technologies and the evaluation cycles may be much longer than in the past.  There can be no assurance that our product and technology development or support efforts will result in new products and services, or that they will be successfully introduced.
 
 
8

 

 
Technology Risks

If we deliver products with defects, our credibility will be harmed and the sales and market acceptance of our products will decrease.

Our products and services are complex and have at times contained errors, defects and bugs.  If we deliver products with errors, defects or bugs, our credibility and the market acceptance and sales of our products would be harmed. Further, if our products contain errors, defects or bugs, we may be required to expend significant capital and resources to alleviate such problems.  We may agree to indemnify our customers in some circumstances against liability arising from defects in our products.  Defects could also lead to product liability as a result of product liability lawsuits against us or against our customers.  We carry product and information liability and errors and omissions insurance, but in the event that we are required to defend more than a few such actions, or in the event that we are found liable in connection with such an action, our business and operations may be severely and materially adversely affected.

Our ANTs Compatibility Server (ACS) product is at an early stage and our business model is not well established.

We began developing the ANTs Compatibility Server in 2007 and have not yet begun selling the product.  We anticipate that we will sell ACS through partners, including the aforementioned large Global IT vendor through the executed OEM agreement.  We have not yet established pricing for ACS and have only preliminary estimates as to the possible revenues and expenses associated with sales, support and delivery.  It is possible that we will not generate enough revenue to offset the expenses and that the ACS line of business will not be profitable.

We will need to continue our product development efforts.

We believe that the market for our products will be characterized by increasing technical sophistication.  We also believe that our eventual success will depend on our ability to continue to provide increased and specialized technical expertise.  There is no assurance that we will not fall technologically behind competitors with greater resources.  Although we believe that we enjoy a lead in our product development, and believe that our patent application for the ACS and trade secrets provide some protection, we will likely need significant additional capital in order to maintain that lead over competitors who have more resources.

We face rapid technological change.

The market for our products and services is characterized by rapidly changing technologies, extensive research and the introduction of new products and services.  We believe that our future success will depend in part upon our ability to continue to develop and enhance ACS and to develop, manufacture and market new products and services. As a result, we expect to continue to make a significant investment in engineering and research and development. There can be no assurance that we will be able to develop and introduce new products and services or enhance our initial products in a timely manner to satisfy customer needs, achieve market acceptance or address technological changes in our target markets.  Failure to develop products and services and introduce them successfully and in a timely manner could adversely affect our competitive position, financial condition and results of operations.

Financing Risks

A failure to obtain financing could prevent us from executing our business plan or operate as a going concern.

We anticipate that current cash resources will be sufficient for us to execute our business plan into the fourth quarter of 2010.  If further financing is not obtained we will not be able to continue to operate as a going concern.  We believe that securing additional sources of financing to enable us to continue the development and commercialization of our proprietary technologies will be difficult and there is no assurance of our ability to secure such financing.  A failure to obtain additional financing could prevent us from making expenditures that are needed to pay current obligations, allow us to hire additional personnel and continue development of our product and technology.  If we raise additional financing by selling equity or convertible debt securities, the relative equity ownership of our existing investors could be diluted or the new investors could obtain terms more favorable than previous investors.  If we raise additional funds through debt financing, we could incur significant borrowing costs and be subject to adverse consequences in the event of a default.
 
 
9

 

We have incurred indebtedness.

We have incurred debt and may incur substantial additional debt in the future.  A significant portion of our future cash flow from operating activities may be dedicated to the payment of interest and the repayment of principal on our indebtedness.  There is no guarantee that we will be able to meet our debt service obligations.  If we are unable to generate sufficient cash flow or obtain funds for required payments, or if we fail to comply with our debt obligations, we will be in default.  In addition, we may not be able to refinance our debt on terms acceptable to us, or at all.  Our indebtedness could limit our ability to obtain additional financing for working capital, capital expenditures, debt service requirements, acquisitions or other purposes in the future, as needed; to plan for, or react to, changes in technology and in our business and competition; and to react in the event of another economic downturn.

Shareholder Risk

There is a limited market for our common stock.

Our common stock is not listed on any exchange and trades in the over-the-counter ("OTC") market.  As such, the market for our common stock is limited and is not regulated by the rules and regulations of any exchange.  Further, the price of our common stock and its volume in the OTC market may be subject to wide fluctuations.  Our stock price could decline regardless of our actual operating performance, and stockholders could lose all or a substantial part of their investment as a result of industry or market-based fluctuations.  Our stock trades relatively thinly.  If a more active public market for our stock is not sustained, it may be difficult for stockholders to sell shares of our common stock.  Because we do not anticipate paying cash dividends on our common stock for the foreseeable future, stockholders will not be able to receive a return on their shares unless they are able to sell them.  The market price of our common stock will likely fluctuate in response to a number of factors, including but not limited to, the following:
 
 
·
sales, sales cycle and market acceptance or rejection of our products;
 
 
·
our ability to sign Partners who are successful in selling our products;
 
 
·
economic conditions within the database industry;
 
 
·
our failure to develop and commercialize the ACS;
 
 
·
the timing of announcements by us or our competitors of significant products, contracts or acquisitions or publicity regarding actual or potential results or performance thereof; and
 
 
·
domestic and international economic, business and political conditions.
 

Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 could have a material adverse effect on our stock price.

Section 404 of the Sarbanes-Oxley Act of 2002 and the related rules and regulations of the SEC require annual management assessments of the effectiveness of our internal control over financial reporting.  If we fail to adequately maintain compliance with, or maintain the adequacy of, our internal control over financial reporting, as such standards are modified, supplemented or amended from time to time, we may not be able to ensure that we can conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 and the related rules and regulations of the SEC.  If we cannot favorably assess our internal controls over financial reporting, investor confidence in the reliability of our financial reports may be adversely affected, which could have a material adverse effect on our stock price.
 
 
10

 

Our actual results could differ materially from those anticipated in our forward-looking statements.

This report contains forward-looking statements within the meaning of the federal securities laws that relate to future events or future financial performance.  When used in this report, you can identify forward-looking statements by terminology such as "believes," "anticipates," "plans," "predicts," "expects," "estimates," "intends," "will," "continue," "may," "potential," "should" and similar expressions.  These statements are only expressions of expectations.  Our actual results could, and likely will, differ materially from those anticipated in such forward-looking statements as a result of many factors, including those set forth above and elsewhere in this report and including factors unanticipated by us and not included herein.  Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.  Neither we nor any other person assumes responsibility for the accuracy and completeness of these statements.  We assume no duty to update any of the forward-looking statements after the date of this report or to conform these statements to actual results.  Accordingly, we caution readers not to place undue reliance on these statements.

Limitation on ability for control through proxy contest.

Our Bylaws provide for a Board of Directors to be elected in three classes.  This classified Board may make it more difficult for a potential acquirer to gain control of us by using a proxy contest, since the acquirer would only be able to elect approximately one-third of the directors at each shareholders’ meeting held for that purpose.

Our securities may be de-listed from the OTC Bulletin Board if we do not meet continued listing requirements.

If we do not meet the continued listing requirements of the OTC Bulletin Board ("OTC") and our securities are de-listed by the OTC, trading of our securities would likely be halted.  In such case, the market for our common stock would be negatively affected and we could face difficulty raising capital necessary for our continued operations.


We have not declared or paid cash dividends or made distributions in the past, and do not anticipate that we will pay cash dividends or make distributions in the foreseeable future.


Additional information regarding our business, properties, legal proceedings, changes in and disagreements with the accountants on accounting and financial disclosure, quantitative and qualitative disclosures about market risk, our "Management's Discussion and Analysis of Financial Condition and Results of Operations," directors and executive officers, executive compensation, security ownership of certain beneficial owners and management and certain relationships, related transactions, and equity compensation plans is incorporated into this prospectus by reference to our Amended Annual Report on Form 10-K/A for the fiscal year ended December 31, 2009, filed with the SEC on April 21, 2010.

Our Annual Reports on Form 10-K and Amended Annual Reports on Form10-K/A, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to reports filed or furnished pursuant to Sections 13(a) and 15 (d) of the Securities and Exchange Act of 1934, as amended, (the “Exchange Act”) are available free of charge on our Investor Relations Web site at www.ants.com as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.  Additional information about the Company can also be found on our website at www.ants.com.
 

We are filing the registration statement of which this prospectus is a part to permit a holder of the shares of our common stock described in the section entitled "Selling Security Holder" to resell such shares. We will not receive any proceeds from the sale of shares by the selling security holder. All net proceeds from the sale of the common stock covered by this prospectus will go to the selling security holder.  However, with respect to shares of common stock issuable upon exercise of an outstanding warrant held by the selling security holder and a potential future warrant to selling security holder, we may receive up to approximately $20,000,000 if all of the outstanding warrants are exercised, unless the selling security holder elects to exercise warrants pursuant to the cashless exercise provisions of the warrants. To the extent the warrants are exercised pursuant to the cashless exercise provisions, we will not receive any proceeds from the exercise of the warrants.  Any proceeds we receive from the exercise of outstanding warrants by the selling security holder will be used for general corporate purposes, which may include working capital, capital expenditures, development costs, strategic investments and possible acquisitions.
 
 
11

 

The selling security holder will pay any underwriting discounts and commissions and expenses incurred by the selling security holder for brokerage, accounting, tax or legal services or any other expenses incurred by the selling security holder in disposing of the shares.  We will bear all other costs, fees and expenses incurred in effecting the registration of the shares covered by this prospectus, including, without limitation, all registration and filing fees, and fees and expenses of our counsel and our accountants.
 

Statements in this Section entitled “Selling Security Holder” contain forward-looking statements that involve a number of uncertainties and assumptions that, if they never materialize or if they prove incorrect, would likely cause our results to differ materially from those expressed or implied by such forward-looking statements.  Although our forward-looking statements reflect the good faith judgment of our management, these statements can only be based on facts and factors currently known by us.  Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from results and outcomes discussed in the forward-looking statements.  For a full recitation of the Company’s statement concerning forward-looking statements, please see the “Special Note Regarding Forward-Looking Statements” in the “Risk Factor” section beginning on page 5 of this prospectus.

On March 12, 2010, we entered into the Stock Purchase Agreement with Fletcher International, Ltd. (“Fletcher”). Pursuant to the terms of the Stock Purchase Agreement, Fletcher purchased 1,500,000 shares of our common stock at $1.00 per share at an initial closing on March 22, 2010, and has the right and, subject to certain conditions, the obligation to purchase up to an additional $8,500,000 of our common stock in multiple closings as described below.  At subsequent closings, Fletcher has the right to purchase (a) up to an aggregate of $500,000 of our common stock at a price per share equal to the Prevailing Market Price (as defined in the Stock Purchase Agreement), (b) up to an aggregate of $3,000,000 of our common stock at a price per share equal to the greater of (i) $1.25 per share, and (ii) the Prevailing Market Price, and (c) up to an aggregate of $5,000,000 of our common stock at a price per share equal to the greater of (i) $1.50 per share, and (ii) the Prevailing Market Price.

Fletcher also received a warrant at the initial closing pursuant to the Stock Purchase Agreement. The warrant issued to Fletcher covers $10,000,000 of our common stock, is exercisable at a price per share of $0.9030 subject to certain adjustments, is exercisable for nine years subject to certain extensions, and is exercisable on a net exercise basis.  If certain conditions are satisfied, the warrant may be replaced with a new warrant covering $10,000,000 of our common stock with an exercise price per share of $3.00 subject to certain adjustments, a term of two years subject to certain extensions, and the same net exercise provisions.  In connection with the shares potentially purchasable and issuable to Fletcher under the subsequent closings and warrant exercises, we have reserved an additional 25,109,536 shares of our common stock in addition to the 1,500,000 shares already purchased by Fletcher.

The shares of common stock to be sold under the Stock Purchase Agreement and the shares of common stock underlying the warrants that are offered for resale by this prospectus are subject to registration obligations pursuant to the terms and conditions of the Stock Purchase Agreement.  We are obligated to file a registration statement with the SEC registering the sale of the shares of common stock and the shares of common stock underlying the warrants and to use our best efforts to cause the registration statement to be declared effective by July 1, 2010.  We are also obligated to use our best efforts to keep the registration statement continuously effective until the earlier of (x) the later of (i) the second anniversary of the issuance of the last share of common stock that may be issued pursuant to the Stock Purchase Agreement or the warrants, and (ii) such time as all of the shares of common stock issued or issuable pursuant to the Stock Purchase Agreement or the warrants can be sold by the selling security holder or any of its affiliates immediately without compliance with the registration requirements of the Securities Act of 1933, as amended, (the “Securities Act”) pursuant to Rule 144 under the Securities Act and (y) the date all of the shares of common stock issued or issuable pursuant to the Stock Purchase Agreement or the warrants shall have been sold by the selling security holder and its affiliates.  This prospectus forms a part of the registration statement that we filed pursuant to the Stock Purchase Agreement.  
 
 
12

 

We are obligated to make payments set forth in the Stock Purchase Agreement to Fletcher in the event that the registration statement is not effective by a certain date, or if we do not maintain its effectiveness in accordance with our agreement.  The payments are equal to 1.5 percent of the aggregate market price of all shares issued and issuable to Fletcher under the Stock Purchase Agreement for each 30 day period, or portion thereof. The factor of 1.5 percent for such payments increases by 0.25 percent for each subsequent 30 day period, or portion thereof.  Assuming share coverage of 26,609,536 common shares and using the closing share price of $0.90 as of March 31, 2010, the Company would be obligated to pay to Fletcher approximately $359,000 for the first 30 days following July 1, 2010 and approximately $419,000 for the next 30 days following July 1, 2010.  Because payments are based in part on the daily common share price, changes in our common share price would change the total amounts payable to Fletcher each subsequent 30 day period and could be significant. The agreement does not provide a limit on the amount that the Company would be obligated to pay to Fletcher for not having an effective Registration Statement. In the event that we owe any of these penalties to Fletcher, we intend to negotiate with Fletcher concerning a waiver, or possible payment of a prorated portion of the penalty relative to the number of shares issued to date.  For purposes of illustration, if the effectiveness of the Registration Statement is delayed for 30 days or less, the Company would negotiate to pay to Fletcher a penalty amount of up to approximately $22,000, assuming a daily volume-weighted average stock price of $0.84, calculated as the product of (1) 1.5%, (2) an assumed daily volume-weighted average stock price of $0.84 and (3) 1,500,000, the total number of shares issued to Fletcher through April 20, 2010.  Nevertheless, the Company will use its reasonable best efforts to have the Registration Statement declared effective by the SEC before July 1, 2010.

The following table sets forth, to our knowledge, certain information about the selling security holder as of March 31, 2010.

Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to shares.  To our knowledge, the entity named in the table has sole voting and investment power with respect to its shares of common stock.  Fletcher’s percentage ownership presented in the table below is based on the number of shares of our common stock outstanding as of March 31, 2010, or 107,236,988 shares.

 
Shares of Common Stock
Beneficially Owned Prior to
Offering
(1, 2)
 
Shares of Common Stock
Beneficially Owned After
Offering
(3)
Name of Selling
Security Holder
Number
Percentage
Number of
Shares of
Common Stock
Being Offered
Number
Percentage
Fletcher
International,
Ltd.
1,500,000
1.4%
26,609,536
------
 
------

 
(1)
This number represents the shares currently held by the selling security holder and does not include any additional shares that may be issued to the selling security holder pursuant to our Stock Purchase Agreement with Fletcher.

 
(2)
Pursuant to the Stock Purchase Agreement and as of June 14, 2010, the aggregate number of shares of common stock issued and issuable under the Stock Purchase Agreement and accompanying warrant may not exceed 10,403,464 shares of common stock (the “Maximum Number”).  The Maximum Number increases upon the occurrence of certain conditions contained in the Stock Purchase Agreement, including after 65 days have elapsed from the time we deliver an increase notice to Fletcher.  The 26,609,536 shares registered in the offering consist of 1,500,000 shares of common stock issued to Fletcher under the Stock Purchase Agreement and also consist of up to 25,109,536 additional shares of common stock that may be issued under the terms and conditions of the Stock Purchase Agreement and accompanying warrants.  No director, executive officer or any associate of any director or executive officer has any interest, direct or indirect, by security holdings or otherwise, in the selling security holder

 
(3)
We do not know when or in what amounts the selling security holder may offer shares for sale.  The selling security holder might not sell any or all of the shares offered by this prospectus.  Because the selling security holder may offer all or some of the shares pursuant to this offering, we cannot estimate the number of the shares that will be held by the selling security holder after completion of the offering.  However, for purposes of this table, we have assumed that, after completion of the offering, none of the shares covered by this prospectus will be held by the selling security holder.
 
 
 
13

 

 
The securities listed above include outstanding securities held in one or more accounts managed by Fletcher Asset Management, Inc. (“FAM”) for Fletcher International, Ltd.  FAM is an investment adviser to Fletcher International, Ltd. and is registered under Section 203 of the Investment Advisors Act of 1940, as amended. Pursuant to an investment advisory agreement between FAM and Fletcher International, Ltd., FAM has the sole authority to vote and dispose of the securities in these accounts.  By reason of the provisions of Rule 13d-3 under the Exchange Act, Fletcher International, Ltd. and FAM may each be deemed to beneficially own the securities registered under the registration statement of which this prospectus is a part.  In addition, by virtue of Alphonse Fletcher, Jr.’s position as Chairman and Chief Executive Officer of FAM, Mr. Fletcher may be deemed to have the shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of, these securities.  For these reasons, Mr. Fletcher may also be deemed to be a beneficial owner of these securities.

Prior to the completion of the private placement to Fletcher, the selling  security holder had not, and none of its affiliates, officers, directors or holders of 5% or more of its share capital has, held any position or office with us or any of our subsidiaries within the past three years.
 
 
The shares of common stock being offered by the selling security holder pursuant to this prospectus have been or will be issued pursuant to an exemption from the registration provisions of the Securities Act.  The shares may be sold or distributed from time to time by the selling security holder, or by pledgees, donees, or transferees of, or other successors-in-interest to, the selling security holder, directly to one or more purchasers (including pledgees) or through brokers, dealers or underwriters who may act solely as agents or who may acquire shares as principals and will act independently of us in making decisions with respect to the timing, manner and size of each sale.

The shares may be sold in one or more transactions at:
 
 
·
fixed prices;
 
·
prevailing market prices at the time of the sale;
 
·
prices related to the prevailing market prices;
 
·
varying prices determined at the time of sale; or
 
·
otherwise negotiated prices.

The selling security holder may sell shares by one or more of, or a combination of, the following methods:

 
·
purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus;
·      ordinary brokerage transactions and transactions in which the broker solicits purchasers;
 
·
block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;
 
·
on any national securities exchange or quotation service on which our common stock may be listed or quoted at the time of sale, including an over-the-counter distribution in accordance with the rules of the NASDAQ National Market;
 
 
14

 
 
·      in privately negotiated transactions;
·      by pledge to secure debts or other obligations;
·      put or call transactions;
·      in options transactions;
·      “at the market” to or through market makers or into an existing market for our common stock;
 
·
in other ways not involving market makers or established trading markets, including direct sales to purchasers or sales effected through agents;
·      to cover hedging transactions made pursuant to this prospectus;
·      underwritten offers;
·      a combination of any such methods of sale; or
·      any other method permitted pursuant to applicable law.

In addition, any shares that qualify for sale pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to this prospectus.  The prospectus may also be used by those to whom a selling security holder may pledge, donate or transfer the shares covered by this prospectus.  To the extent required, this prospectus may be amended or supplemented from time to time to reflect any pledgee, donee, transferee or successors that may offer shares under this prospectus and to describe a specific plan of distribution or transaction.

Broker-dealers engaged by the selling security holder may arrange for other broker-dealers to participate in sales.  Broker-dealers may receive commissions or discounts from the selling security holder (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with NASD Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with NASD IM-2440.

In connection with sale of common stock or otherwise, the selling security holder may (1) enter into transactions with broker-dealers, financial institutions or others, who in turn may engage in sales, including short sales, of the shares in the course of hedging the positions they assume, (2) deliver shares to close out positions entered into with broker-dealers, financial institutions or others or (3) loan shares to broker-dealers, financial institutions or others that may in turn sell such shares.  The broker-dealers, financial institutions or others referred to in (1) above may engage in those transactions referred to in (1), (2) or (3) above through this prospectus.  The selling security holder may enter into option, swap or other transactions with broker-dealers, financial institutions or others that require the delivery to the broker-dealers, financial institutions or others of the shares.  The broker-dealer, financial institution or others may then resell or transfer these shares through this prospectus.  The selling security holder may also loan or pledge their shares to a broker-dealer or other financial institution.  The broker-dealer or financial institution may sell the shares which are loaned or pursuant to a right to rehypothecate while pledged or, upon a default, the broker-dealer or other financial institution may sell the pledged shares by use of this prospectus. The broker-dealer or other financial institution may use shares pledged by the selling security holder or borrowed from the selling security holder or others to settle those sales or to close out any related open borrowings of shares, and may use securities received from the selling security holder in settlement of those derivatives to close out any related open borrowings of shares.

Some or all of the shares offered in this prospectus may also be sold to or through an underwriter or underwriters.  Any shares sold in that manner will be acquired by the underwriters for their own accounts and may be resold at different times in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale.  These shares may be offered to the public through underwriting syndicates represented by one or more managing underwriters or may be offered to the public directly by one or more underwriters.  Any public offering price and any discounts or concessions allowed or disallowed to be paid to dealers may be changed at different times.

In offering the shares covered by this prospectus, the selling security holder and any broker-dealers who execute sales for the selling security holder may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales.  Any profits realized by the selling security holder and the compensation of any broker-dealer may be deemed to be underwriting discounts and commissions.  We have agreed to indemnify the selling security holder against certain liabilities, including certain liabilities under the Securities Act.
 
 
15

 

Because the selling security holder may be deemed to be an “underwriter” within the meaning of the Securities Act, it will be subject to the prospectus delivery requirements of the Securities Act.  In addition, any securities covered by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than under this prospectus.  Neither the delivery of any prospectus, or any prospectus supplement, nor any other action taken by the selling security holder or any purchaser relating to the purchase or sale of shares under this prospectus shall be treated as an admission that any of them is an underwriter within the meaning of the Securities Act relating to the sale of any shares.  The selling security holder has advised us that it has not entered into any written or oral agreements, understandings or arrangements with any underwriter or broker-dealer regarding the sale of the shares of common stock.  There is no underwriter or coordinating broker acting in connection with the proposed sale of the shares of common stock by the selling security holder.

We have agreed with the selling security holder to keep the Registration Statement of which this prospectus constitutes a part effective until the earlier of (i) such time as all of the shares covered by this prospectus have been disposed of pursuant to and in accordance with the Registration Statement or (ii) until the later of (x) the second (2nd) anniversary of the issuance of the last security covered by this Registration Statement that may be issued, or (y) such time as all of the securities covered by this Registration Statement issued or issuable hereunder can be sold by Fletcher or any of its affiliates immediately without compliance with the registration requirements of Rule 144 under the Securities Act.

Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the shares of common stock may not simultaneously engage in market making activities with respect to the common stock for a period of two business days prior to the commencement of the distribution.  In addition, the selling security holder will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, which may limit the timing of purchases and sales of shares of the common stock by the selling security holder or any other person.  We will make copies of this prospectus available to the selling security holder and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale.

There is no guarantee that the selling security holder will sell any of our common stock.
 

Common Stock

This Registration Statement, of which this prospectus is a part, covers 26,609,536 shares of our Common Stock.

As of March 31, 2010, there were 107,236,988 shares of our common stock outstanding and held of record by 1,385 stockholders.  We have 9,678,387 shares of Series A convertible preferred stock outstanding held of record by 4 stockholders.  The Series A convertible preferred stock is convertible into shares of common stock at a conversion ratio of approximately 2.85714 shares of common stock for each share of Series A convertible preferred stock, subject to possible adjustments 

Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights.  An election of directors by our stockholders will be determined by a plurality of the votes cast by the stockholders entitled to vote on the election.  Holders of common stock are entitled to receive proportionately any dividends as may be declared by our board of directors, subject to preferential dividend rights of outstanding preferred stock.

In the event of our liquidation or dissolution, the holders of common stock are entitled to receive proportionately our net assets available for distribution to stockholders after the payment of all debts and other liabilities and subject to the preferential rights of outstanding preferred stock.  Holders of common stock have no preemptive, subscription, redemption or conversion rights.  Our outstanding shares of common stock are validly issued, fully paid and nonassessable.  The rights, preferences and privileges of holders of common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future.
 
 
16

 
 
Delaware Anti-takeover Law and Certain Charter and By-Law Provisions

Delaware Law
        
We are subject to Section 203 of the Delaware General Corporation Law. Subject to certain exceptions, Section 203 prevents a publicly-held Delaware corporation from engaging in a “business combination” with any “interested stockholder” for three years following the date that the person became an interested stockholder, unless either (1) the interested stockholder attained such status with the approval of our board of directors, or (2) the business combination is approved by our board of directors and stockholders in a prescribed manner or (3) the interested stockholder acquired at least 85% of our outstanding voting stock in the transaction in which it became an interested stockholder.  A “business combination” includes, among other things, a merger or consolidation involving us and the “interested stockholder,” the sale of more than 10% of our assets, and other transactions resulting in a financial benefit to the interested stockholder.  In general, an “interested stockholder” is any entity or person beneficially owning 15% or more of our outstanding voting stock and any entity or person affiliated with or controlling or controlled by such entity or person.  This provision may discourage or prevent unsolicited tender offers for our outstanding common stock.

Staggered Board
        
In accordance with the terms of our Amended and Restated Certificate of Incorporation and Amended and Restated By-Laws, our board of directors is divided into three classes, class I, class II and class III, with members of each class serving staggered three-year terms.  Our Amended and Restated Certificate of Incorporation provides that the authorized number of directors may be changed only by resolution of the board of directors.  Any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors.  Our Amended and Restated Certificate of Incorporation and our Amended and Restated By-Laws also provide that our Board of directors may declare vacant the office of a director who has been declared of unsound mind by an order of court or who has been convicted of a felony.  Further, the entire board of directors or any individual director may be removed from office without cause by a vote of the shareholders holding a majority of the outstanding shares entitled to vote at an election of directors.  Any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of our directors then in office.  Our classified board could have the effect of delaying or discouraging an acquisition of the Company or a change in our management.

Stockholder Action; Special Meeting of Stockholders
        
Our Amended and Restated Certificate of Incorporation and our Amended and Restated By-Laws provide that any action required or permitted to be taken by our stockholders at an annual meeting or special meeting of stockholders may also be taken by written action in lieu of a meeting, without notice, if signed by the holders of outstanding shares having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.

Our Amended and Restated Certificate of Incorporation and our Amended and Restated By-Laws also provide that, except as otherwise required by law, special meetings of the stockholders may be called at any time by the Chairman of the Board, the Lead Director, the Chief Executive Officer, the President or Vice President, or by the Board of Directors, or by one or more stockholders holding shares in the aggregate entitled to cast not less than ten percent (10%) of the votes at that meeting.
 

 The validity of the issuance of the common stock offered by this prospectus will be passed upon for us by The Corporate Law Group.  Members of the family of Paul Marotta, the principal in The Corporate Law Group, own 12,000 shares of Company common stock.

The financial statements, incorporated in this prospectus by reference from the Company’s Amended Annual Report on Form 10-K/A Amendment No. 1 for the year ended December 31, 2009, have been audited by Weiser LLP, an independent registered public accounting firm, as stated in their report, which is incorporated herein by reference.  Such financial statements have been so incorporated in reliance upon the report of such firm given upon their authority as experts in accounting and auditing.
 
 
 
17

 
 

Additional Information

Additional information regarding our business, properties, legal proceedings, changes in and disagreements with the accountants on accounting and financial disclosure, quantitative and qualitative disclosures about market risk, our "Management's Discussion and Analysis of Financial Condition and Results of Operations," and additional information regarding our directors and executive officers, executive compensation, security ownership of certain beneficial owners and management and certain relationships, related transactions, and equity compensation plans are incorporated into this prospectus by reference to our Amended Annual Report on Form 10-K/A for the fiscal year ended December 31, 2009, filed with the SEC on April 21, 2010.

Our Annual Reports on Form 10-K, Amended Annual Reports on Form 10-K/A, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, Proxy Statements and amendments to reports filed or furnished pursuant to Sections 13(a) and 15 (d) of the Exchange Act are available free of charge on our Investor Relations Web site at www.ants.com as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.  Additional information about the Company can also be found on our website at www.ants.com.

Additionally, the public may read and copy any materials filed with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549.  The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.  The SEC also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC and can be found at www.sec.gov.

The Company

ANTs software inc. (“ANTs”, “we” or the “Company”) developed a software solution, the ANTs Compatibility Server (“ACS”), to allow customers to move software applications from one database product to another without time consuming and costly database migrations and application rewrites.  ACS translates the languages used by database products so that software applications written for one database product will work with another.  ACS allows customers to replace the database product without replacing the software application.

Corporate History

ANTs is a Delaware corporation headquartered in San Francisco, California.  Our shares are traded on the OTC Bulletin Board under the stock symbol ANTS.  We are the successor to Sullivan Computer Corporation, a Delaware corporation incorporated in January 1979, which, in 1986 changed its name to CHoPP Computer Corporation.  In 1997, we reincorporated from Delaware to Nevada, and in February 1999 changed our name to ANTs software.com.  In July 2000, we merged with Intellectual Properties and Technologies, Inc., a wholly owned subsidiary with no significant assets.  In December 2000, we reincorporated from Nevada to Delaware and changed our name from ANTs software.com to ANTs software inc.

In May 2008, ANTs acquired Inventa Technologies Inc. (“Inventa”) of Mt. Laurel, New Jersey.  Inventa is a wholly-owned subsidiary that manages and optimizes applications and databases for large enterprises.  Inventa is the services division of ANTs, providing installation and support services for the ACS.
 
 
18

 

Technology and Intellectual Property

Beginning in 2000, we focused on development of the ANTs Data Server (“ADS”) and core high-performance database technologies.  In May 2008, we sold ADS and the high-performance technologies and intellectual property related to it, while retaining a license to use those technologies in the ACS.  The sale of the ADS technology and related licensing agreements were recorded as revenue in the 2008 financial statements for a total of $4.3 million or approximately 52% of that year’s revenue.  In 2007, we began developing ACS and launched the first commercial version in April 2008.  We have developed proprietary technologies related to ACS which we regard as trade secrets and we are pursuing patent protection on a number of these technologies. Inventa has also developed proprietary technologies used in the monitoring and management of applications and databases.  We regard these technologies as trade secrets.

The ANTs Compatibility ServerTM

Applications written to work with one database product are typically incompatible with other database products due to proprietary extensions developed and popularized by the database vendors.  This has the effect of locking customers into one database vendor because it would generally be cost-prohibitive and too time-consuming to migrate an application from one database to another.  ACS translates these proprietary extensions from one database product to another and allows customers to migrate applications from one database product to another more easily and at less cost.

Migrating applications is intended to be a three-step process when using ACS:
 
 
1.
Move the data - the large database vendors all have full-featured tools that allow customers to move data from other products to theirs.
 
 
2.
Install ACS - once the data is migrated, ACS is installed and connected to the application and the new database.
 
 
3.
Test and deploy - the application is first tested to ensure that it functions properly with the new database, and then the customer goes "live" with the application.

We have developed the underlying technologies related to ACS with the first version of ACS allowing applications currently running on Sybase's database product to run on Oracle's database product.  During 2008, ANTs completed pilots for an early group of customers and in December 2008 announced its first commercial deployment with the Wyndham Hotel Group call center application. In the future, we expect to build versions of ACS that will enable applications to be migrated from and to numerous other database products.

Professional Services

Established in 1993, Inventa, our IT managed services and professional services division, provides pre- and post-sales services related to the ACS and application migration, application and database architecting, monitoring and management.  Inventa provides the following services:

ACS Services.  This service assists customers in establishing a database consolidation strategy, action plan for migrating applications among databases, installation, deployment and post-deployment monitoring and tuning.

Monitoring Infrastructure Management.  This service provides management of monitoring infrastructure including: architecture planning, agent deployment and support, and agent configuration with threshold management.  The core infrastructure for this service can either be hosted and managed by us or deployed directly within a customer’s environment and individual events / alarms transitioned back to customer employees.

Monitoring and Event Management.  This service provides a fully functional 24x7x365 Network Operations Center (“NOC”) responsible for isolating critical events, opening trouble tickets, and escalating the event’s visibility within the customer’s organization.  This service can be hosted entirely within our NOC or portions can be integrated with or hosted directly within the customer’s environment.

Visualization and Trending.  Our ESM Integrator™ portal captures, centralizes and integrates performance metrics collected by the monitoring infrastructure deployed as a component of our other services or layered upon existing data sources residing within the customer’s environment.  Sources of data are not limited to components monitored by our service; we can integrate virtually any business metrics, or other third party data for enterprise-wide reporting which is platform independent.
 
19

 
 
Performance Management.  The most popular way organizations attempt to solve their performance issues is with faster, more powerful hardware.  While this generally produces some positive results, the benefit is very costly in both hardware and tiered software.  Additionally, performance is typically addressed only when business or system reliability is impacted thereby creating additional pressure to the already constrained customer staff to fix the issue.  Our Performance Management Service is pro-active and can help maximize the customer’s existing resources in a cost-effective and manageable way.

Capacity Planning.  This service provides organizations with the ability to anticipate the effects of growth and plan for that growth.  Customers are able to map out a strategy to accommodate spikes in transaction volumes and overall growth while maintaining response time and uptime.

Code Quality Management.  Performance quality, reliability, and capacity are results of how well applications are designed and implemented.  Our Code Quality Management service uses our time-tested code analysis tools to assist customers in tracking overall code quality and improvements as new application versions are released.

We provide Professional Services to customers in the hospitality, banking, insurance, gaming, automotive and high-technology industries.  We have extensive experience in architecting enterprise application and database deployments, upgrades and migrations and in installing, configuring, deploying and maintaining database products from major vendors such as IBM, Oracle, Microsoft and Sybase.  We have developed proprietary software that enables us to remotely monitor, diagnose and maintain customer applications and databases, saving customers the cost of having to maintain in-house IT resources needed to deliver these services.  We typically sign annual and multi-year contracts and the majority of our customers renew.

We deliver our services through a remote delivery model from our Mount Laurel, New Jersey office which contains a network operations center. The network operations center provides customers with remote assessment, diagnostic and tuning capabilities through secure remote connection 24 hours a day, seven days a week. We integrate our Professional Services capabilities tightly into the pre and post-sales process, enabling us to:
 
·           Accurately assess the customer’s operating environment;
 
·           Propose the most efficient database consolidation and application migration solution;
 
·           Efficiently deploy ACS and assist the customer in testing before “going live”; and
 
·           Post-deployment, provide application monitoring, maintenance and service past deployment.

Sales and Marketing
 
The Market

According to IDC Research, the market for database products was $20 billion in 2008.   Oracle, Microsoft and IBM control approximately 83% of this market.  According to the numerous Chief Technology Officers, database architects and application developers at the target Global 2000 enterprises with whom we have spoken, database infrastructure costs have become one of the most expensive line items in the IT budget.  These Global 2000 enterprises typically have annual database "spends" in excess of tens and, in some cases, hundreds of millions of dollars and their database budgets are growing annually.  The migration cost from one database to another, even to a low-cost open-source database, is extensive due to lack of compatibility between the products' proprietary extensions.  There is significant interest, confirmed by our discussions with industry analysts and user groups, for a product that can provide the capability to migrate an application from one database to another.

 
20

 
Also according to IDC Research, the markets in which our Professional Services group operates, IT services and application management, was projected at $122 billion in 2007 with IBM Global Services, HP/EDS and Accenture being among the largest vendors in those markets.  We have a unique combination of experience, skills and proprietary software that allow us to address a segment of the IT services market centered on database and application monitoring, maintenance and services.  In addition to this established market, we anticipate that our Professional Services group will be the first provider of migration and consulting services resulting from pre- and post-sales of our ACS products.  We expect our ACS customers will look to us as the experts in database consolidation to provide a full range of services related to ACS installation, deployment and use.  To the extent that this becomes a new "market" for Professional Services, we are in a position to capitalize on it.

Our Strategy

Our go-to-market strategy adapts with changes in the competitive structure of the database market.  The refinement of our strategy is a continuous and iterative process, reflecting our goal of providing a cost-effective solution across a wide variety of applications.  Our strategy has recently included:
 
 
·
Developing partnerships with IBM, Oracle, Microsoft, Sybase and others to bring our products to market;
 
 
·
Focusing on large enterprise customers who can realize significant savings by migrating applications among leading database products;
 
 
·
Selling or licensing our products directly;
 
 
·
Selling our products and technologies through partners; and
 
 
·
Developing custom versions of our products for our partners and selling or licensing that technology to them.
 
ACS can provide a solution for enterprises to address the problems of vendor lock-in and cost escalation by enabling them to migrate applications among database products.  ACS can provide a potentially significant competitive advantage for database vendors such as Oracle, IBM, Microsoft, Sybase and others because they would have the ability to cost-effectively migrate applications from their competitors’ products to their own.

If we are successful in our go-to-market strategy, we intend to generate revenue through a range of activities which may include: sales of developed technology, licenses, royalties, custom development and Professional Services.   If one or more of the large database vendors resells our products, we would expect to share in that license and maintenance revenue.  Each sale of our products or related technology will require installation, testing, tuning and other Professional Services.  We intend to generate revenue by providing those services.

We generated significant revenues totaling $4.3 million, or 52% of 2008 revenues, related to the license and sale of our ADS technologies during the year-ended December 31, 2008.  We expect to generate revenues from existing and new contracts with our Professional Services customers, and if successful, we expect to generate additional revenues related to ACS.

In August 2009, the Company announced that negotiations had been completed regarding the supply of database migration technology to a Global IT vendor.  An OEM Agreement has been completed and signed by both parties.  Confidentiality provisions of the OEM Agreement preclude the naming of the vendor until approved by both parties.  The Company anticipates substantial business and future revenue to be generated from this agreement.  According to the OEM Agreement, ANTs is responsible for technology development specifically tailored to the Global IT vendor needs.  The Global IT vendor will assume responsibility for marketing, sales and support of the technology on a worldwide basis, while ANTs will be the preferred service provider for migration projects.

Competition

We have not identified a direct competitor for our ACS database migration products.  Other database vendors encourage migration from competitive products through use of their proprietary migration tools.  These tools often require substantial investment to rewrite applications.  Potential customers with whom we have spoken are not receptive to these migrating applications due to the expense and risk of such rewrites.  While database vendors do not offer a directly competitive product, we fully expect database vendors to offer incentives for customers to keep applications deployed on their database products.

 
21

 
Competitors in the Professional Services market are large and well-established, with vendors such as IBM Global Services, Accenture and HP/EDS offering a wide range of services.  We have maintained long-term relationships with our customers and have been successful in renewing contracts and in signing multi-year contracts.

Current Operations

Our operations consist of:

 
·
Developing Database Migration Technologies and the ACS – we develop and market ACS, a faster, cost-effective way to consolidate databases, allowing customers to efficiently use IT resources and drive down operating costs.

 
·
Professional Services – we have extensive experience in architecting enterprise application and database deployments, upgrades and migrations and in installing, configuring, deploying and maintaining database products from major vendors such as IBM, Oracle, Microsoft and Sybase. We provide application migration services, application and database managed services and consulting services.

We have financed operations through private offerings to accredited investors and asset managers to whom we have sold common stock and issued convertible promissory notes and warrants.  We expect to continue to raise capital for operations through such private offerings until we generate positive cash flows from operations.  We believe we have sufficient funds to cover operations into the fourth quarter of 2010 at our expected expense rate.  We expect that our focus over the next year will be on the continued development, marketing and sales of ACS and on the growth of our Professional Services offerings.

Employees

As of April 20, 2010, we had 65 full-time employees, all based in the United States.  We have not experienced work stoppages, are not subject to any collective bargaining agreement and believe that our relationship with our employees is good.


Our headquarters are located in San Francisco, California under a short-term lease. We maintain a facility in Mt. Laurel, New Jersey, where we lease approximately 12,000 square feet of office space as of December 31, 2009. On September 9, 2009, the Company entered into a one year lease for office space in Alpharetta, Georgia, beginning on November 1, 2009 for 1,500 square feet of office space for rent of $1,000 per month. On February 3, 2010, the Company amended the Alpharetta lease to rent an additional 1,500 square feet for additional rent of $1,050 per month through November 1, 2010.


On July 10, 2008, Sybase, Inc. (“Sybase”), an enterprise software and services company, filed a complaint for common law unfair business practices, and tortious interference with contractual relations, among other things, in the Superior Court of the State of California, County of Alameda.  Sybase is seeking an injunction, and damages, among other legal and equitable relief.  A trial has been set for August 2010.  The Company believes that this lawsuit is without merit and intends to continue vigorously defending itself.

On August 22, 2008, a former ANTs employee filed a putative class action complaint for all current and former software engineers, for failure to pay overtime wages, and failure to provide meal breaks, among other things, in Superior Court of the State of California, County of San Mateo.  The former employee is seeking an injunction, damages, attorneys’ fees, and penalties.  The Company believes that this lawsuit is without merit and intends to continue vigorously defending itself.

 
22

 
On October 14, 2008, Bayside Plaza (“Bayside”), a partnership, filed a complaint for breach of contract in Superior Court of the State of California, County of San Mateo.  Bayside was seeking approximately $50,000 in rent, late fees and operating expenses per month from October 2008.  The Company settled the complaint by paying $50,000 in May 2009 and agreeing to pay $25,000 in each of August 2009, November 2009 and February 2010. As of the date of the settlement in May 2009, the Company had accrued a liability of approximately $404,000. As a result, the Company recognized a gain on the settlement of approximately $279,000 as an offset to rent expense, which is included in General and Administrative Expense in the Consolidated Statement of Operations at December 31, 2009.

On September 9, 2009, Ken Ruotolo, a former employee and officer of the Company, filed a complaint for breach of contract, breach of the covenant of good faith and fair dealing and declaratory relief, in the Superior Court of the State of California, County of San Francisco. Mr. Ruotolo is seeking damages, attorneys’ fees and declaratory relief. A trial has been set for September 2010.  The Company believes that this lawsuit is without merit and intends to continue vigorously defending itself. Mr. Ruotolo’s father, Francis K. Ruotolo, is a Director of the Company.

On January 14, 2010, three lawsuits were filed against the Company by Robert T. Healey.  The first of these lawsuits, against the Company, demands inspection of the Company’s books and records.  The second lawsuit, against the Company, and its 8 directors (including former director Tom Holt), is alleged to be brought by Mr. Healey “both individually and derivatively,” therein alleging various wrongdoing by the Company and its directors.  The third lawsuit, against the Company and its 8 directors (including former director Tom Holt), is brought by Mr. Healey for a declaration directing the Company to nominate Mr. Healey and Rick Cerwonka (the Company’s Chief Operating Officer and the President of the Company’s subsidiary, Inventa Technologies, Inc.) for election to the Company’s Board of Directors.  The Company has created a committee to evaluate the derivative action and has begun responding to these lawsuits.  A trial on declaratory issues in the third lawsuit is set for early June 2010.


Our common equity is traded on the Over-The-Counter Bulletin Board ("OTCBB") under the symbol "ANTS."
 
The following is the range of high and low closing bid prices of our stock, for the periods indicated below.
 

 
High
Low
Quarter Ended June 30, 2010 (through April 20, 2010)
$0.92
$0.79
Quarter Ended March 31, 2010
$1.00
$0.61
     
Quarter Ended December 31, 2009
$0.97
$0.45
Quarter Ended September 30, 2009
$0.57
$0.26
Quarter Ended June 30, 2009
$0.69
$0.34
Quarter Ended March 31, 2009
$0.74
$0.31
     
Quarter Ended December 31, 2008
$0.71
$0.30
Quarter Ended September 30, 2008
$0.92
$0.52
Quarter Ended June 30, 2008
$1.26
$0.80
Quarter Ended March 31, 2008
$1.30
$0.71
 
The quotations reflect inter-dealer prices, without retail mark-up, markdown or commission and may not represent actual transactions.

 
23

 
As of March 31, 2010 there were 107,236,988 and 9,678,387 shares of common and Series A convertible preferred stock, respectively, issued and outstanding. As of March 31, 2010 there were 1,385 and 4 registered holders of record of our common and preferred stock, respectively.

As of April 20, 2010, the last reported sale price of our common stock on the Over-the-Counter bulletin board system was $0.89.

 
We have not declared or paid cash dividends or made distributions in the past, and do not anticipate that we will pay cash dividends or make distributions in the foreseeable future.


The information required by this item is incorporated in this prospectus by reference to the Company’s Amended Annual Report for the fiscal year ended December 31, 2009, on Form 10-K/A filed with the SEC on April 21, 2010.


The information required by this item is incorporated in this prospectus by reference to the Company’s Amended Annual Report for the fiscal year ended December 31, 2009, on Form 10-K/A filed with the SEC on April 21, 2010.


There have been neither changes in nor disagreements with accountants on accounting and financial disclosure during the previous fiscal year ending December 31, 2009.


The information required by this item is incorporated in this prospectus by reference to the Company’s Amended Annual Report for the fiscal year ended December 31, 2009, on Form 10-K/A filed with the SEC on April 21, 2010.


The information required by this item is incorporated in this prospectus by reference to the Company’s Amended Annual Report for the fiscal year ended December 31, 2009, on Form 10-K/A filed with the SEC on April 21, 2010.


The information required by this item is incorporated in this prospectus by reference to the Company’s Amended Annual Report for the fiscal year ended December 31, 2009, on Form 10-K/A filed with the SEC on April 21, 2010.


The following table sets forth, as of March 31, 2010, information regarding ownership of the Company’s common stock by:
 
 
·
each person known by the Company, based on filings pursuant to Section 13(d) or (g) under the Exchange Act, to own beneficially more than 5% of the outstanding shares of our common stock as of December 31, 2009;
 
·
the persons named in the Summary Compensation Table; and
 
·
all directors and executive officers as a group.

 
24

 
Unless otherwise indicated, the address of each director and officer is: c/o ANTs software inc., 71 Stevenson Street, Suite 400, San Francisco, California 94105.

Name and Address of Beneficial Owner
 
Number of Shares
of Common Stock (14)
   
Percent of Class
 
 
Constantin Zdarsky (1)
   c/o Time Hanlon, Alley, Maass, Rogers & Lindsay, P.A.
   340 Royal Poinciana Way, Ste. 321,
   Palm Beach, FL 33480
    30,759,676       17.5 %
 
Lyle P. Campbell (2)
   c/o Berry-Shino Securities, Inc.
   15100 N. 78th Way, Suite #100
   Scottsdale, AZ 85260
    12,914,200       7.4 %
                 
Alton Dinsmore
    362,083       *  
Kenneth Markovich
    243,889       *  
 
Directors and Executive Officers
               
Joseph Kozak (3)
    1,591,333       *  
Francis K. Ruotolo (4)
    909,018       *  
John R. Gaulding (5)
    392,232       *  
Robert H. Kite (6)
    743,750       *  
Craig Campbell (7)
    5,525,105       3.1 %
Ari Kaplan (8)
    172,291       *  
Robert Jett (9)
    167,768       *  
David Buckel (10)
    103,298       *  
Rick Cerwonka (11)
    306,937       *  
Former Officer:
               
Kenneth Ruotolo (12)
    12,000       *  
All directors and executive officers as a group (9 persons) (13)
    9,849,232       5.6 %

* Less than one percent
 
(1)
Includes 9,745,700 shares of common stock owned by Mr. Zdarsky, warrants to purchase up to 7,502,151 shares of common stock, and the right to acquire 13,511,825 shares of common stock pursuant to Convertible Preferred Stock and Convertible Preferred Stock Warrants.

(2)
Includes 3,914,200 shares of common stock owned by Mr. Lyle Campbell and the right to acquire 9,000,000 shares of common stock pursuant to Convertible Preferred Stock.

(3)
Includes 38,000 shares of common stock purchased on the open market by Mr. Kozak, a stock grant of 62,500 common shares and vested options to purchase up to 1,490,833 shares of common stock. Unvested options of 9,167 are excluded.

 
25

 
(4)
Includes 97,143 shares of common stock purchased by Mr. Ruotolo through a private offering, approved by the Company’s Board of Directors and directed to certain accredited investors, 10,000 shares of common stock purchased on the open market, a stock grant of 50,000 common shares and vested options to purchase up to 751,875 shares of common stock.  Unvested options of 400,000 are excluded.

(5)
Includes 62,857 shares of common stock purchased by Mr. Gaulding through a private offering, approved by the Company’s Board of Directors and directed to certain accredited investors, a stock grant of 50,000 common shares, warrants to purchase up to 229,375 shares of common stock and vested options to purchase up to 50,000 shares of common stock.  Unvested options of 490,000 are excluded.

(6)
Includes 325,000 shares of common stock purchased by Mr. Kite through a private offering, approved by the Company’s Board of Directors and directed to certain accredited investors, 125,000 shares of common stock purchased through the exercise of warrants, warrants to purchase up to 183,750 shares of common stock, and vested options to purchase up to 110,000 shares of common stock. Unvested options of 320,000 are excluded.

(7)
Includes 895,939 shares of common stock purchased by Mr. Craig Campbell through a private offering, approved by the Company’s Board of Directors and directed to certain accredited investors, the right to acquire 4,500,000 shares of common stock pursuant to convertible Preferred Stock, and vested options to purchase 129,166 shares of common stock.  Unvested options of 308,334 are excluded.
 
(8)
Includes vested options to purchase 172,291 shares of common stock by Mr. Kaplan. Unvested options of 308,334 are excluded.
 
(9)
Includes 15,625 shares of common stock purchased by Mr. Jett through a private offering, approved by the Company’s Board of Directors and directed to certain accredited investors, 27,143 shares of common stock purchased by Mr. Jett on the open market, a stock grant of 50,000 common shares and vested options to purchase 75,000 shares of common stock.  Unvested options of 400,000 are excluded.
 
(10)
Includes 62,500 shares of common stock purchased by Mr. Buckel through a private offering, approved by the Company’s Board of Directors and directed to certain accredited investors, a stock grant of 13,021 common shares to Mr. Buckel and vested options to purchase up to 27,777 shares of common stock. Unvested options of 472,223 are excluded.
 
(11)
Includes a stock grant of 62,500 common shares to Mr. Cerwonka and vested options to purchase up to 244,437 shares of common stock. Unvested options of 155,563 are excluded.
 
(12)
Includes 12,000 shares of common stock purchased through a private offering, approved by the Company’s Board of Directors.  On June 18, 2009, Kenneth Ruotolo, former Chief Financial Officer and Secretary, terminated his employment with the Company under his 2007 Employment Agreement.
 
(13)
This calculation does not include the beneficial ownership of the former officer who was named executive officer.
 
(14)
Beneficial ownership is determined in accordance with the rules of the SEC and derives from either voting or investment power with respect to securities. Shares of common stock issuable upon conversion of the promissory notes or shares of common stock issuable upon exercise of warrants and options currently exercisable, or exercisable within 60 days of March 31, 2010, are deemed to be beneficially owned for purposes hereof. There were 107,236,988 shares of common stock outstanding as of March 31, 2010. For purposes of computing the percentages under this table, 175,764,277 shares of common stock were treated as issued and outstanding as of March 31, 2010.
 

Related Transactions

From January 1, 2008 through April 20, 2010, there were no transactions, and there are no proposed transactions, in which we were or are to be a participant, involving an amount in excess of $120,000, and in which any related person had or will have a direct or indirect material interest, except for the $50,000 quarterly payments made to Francis Ruotolo from June 2007 through September 2009 as more fully described below under Executive Compensation Discussion and Analysis.

 
26

 
The Audit Committee of the Company’s Board of Directors is responsible for reviewing any transaction with related persons and making recommendations to the Board of Directors for consideration.

Director Independence

The entire Board of Directors, with the exception of Joseph Kozak, Francis Ruotolo and Ari Kaplan are “Independent” directors, as defined by applicable rules and regulations of the SEC and NASDAQ Stock Market.  The Company deems Francis Ruotolo to be not independent, on the basis of his previous employment with the Company.  Mr. Ruotolo has been employed by the Company within the past three years and has received payments in excess of the $120,000 threshold in 2008 and 2009.  The Company deems Ari Kaplan to be not independent because he has received consulting fees from the Company which total more than $100,000 by the date of this report.

Beneficial Investor and Director Relationship

As noted in the Beneficial Shareholder’s table included herein, Lyle P. Campbell is a beneficial shareholder of 7.35% of the common stock of the Company.  In May, 2007, Mr. Campbell’s son, Craig Campbell, joined the Company’s Board of Directors.  Mr. Craig Campbell is also a direct shareholder of the Company, beneficially owning 3.14% of the Company’s common stock.

Recent Actions

On January 14, 2010, three lawsuits were filed against the Company by Robert T. Healey.  The first of these lawsuits, against the Company, demands inspection of the Company’s books and records.  The second lawsuit, against the Company, and its 8 directors (including former director Tom Holt), is alleged to be brought by Mr. Healey “both individually and derivatively,” therein alleging various wrongdoing by the Company and its directors.  The third lawsuit, against the Company and its 8 directors (including former director Tom Holt), is brought by Mr. Healey for a declaration directing the Company to nominate Mr. Healey and Rick Cerwonka (the Company’s Chief Operating Officer and the President of the Company’s subsidiary, Inventa Technologies, Inc.) for election to the Company’s Board of Directors.  The Company has created a committee to evaluate the derivative action and has begun responding to these lawsuits.  A trial on declaratory issues in the third lawsuit is set for early June 2010.


The information required by this item is incorporated in this prospectus by reference to the Company’s Amended Annual Report for the fiscal year ended December 31, 2009, on Form 10-K/A filed with the SEC on April 21, 2010.
 
 

The Company elects to incorporate information by reference to its Amended Annual Report for the fiscal year ended December 31, 2009 on Form 10-K/A, filed with the SEC on April 21, 2010, its Quarterly Reports on Form 10-Q and its Current Reports on Form 8-K, all of which can be found on the SEC website at www.sec.gov or on the Company’s website at www.ants.com.  There have been no material changes in the Company’s affairs since the end of the most recent fiscal year which have not been described on the Company’s Quarterly Reports on Form 10-Q or on the Company’s Current Reports on Form 8-K filed with the SEC under the Exchange Act.
 
 
There are hereby incorporated by reference in this prospectus the following documents and information heretofore filed with the SEC:
 
 
27

 

 
(a)
Our Amended Annual Report on Form 10-K/A for the fiscal year ended December 31, 2009, filed with the SEC on April 21, 2010;
  
 
(b)
Our Annual Report on Form 10-K for the fiscal year ended December 31, 2009, filed with the SEC on March 31, 2010;
 
 
(c)
Our Current Reports on Form 8-K, filed with the SEC on March 19, 2010, March 15, 2010, February 11, 2010 and January 28, 2010;

 
(d)
Our Definitive Proxy Statement on Schedule 14A, filed with the SEC on January 29, 2010; and

 
(e)
The description of Our common stock contained in Our Form 10SB12G filed with the SEC on September 14, 1999 including any amendment or report filed for the purpose of updating such description.
 
Also incorporated by reference are all documents that we may file with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act after the initial filing of the Registration Statement of which this prospectus is a part, and before we stop offering the securities described in this prospectus.  These documents include periodic reports, such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, as well as proxy statements.  Pursuant to General Instruction B of Form 8-K, any information submitted under Item 2.02, Results of Operations and Financial Condition, or Item 7.01, Regulation FD Disclosure, of Form 8-K is not deemed to be “filed” for the purpose of Section 18 of the Exchange Act, and we are not subject to the liabilities of Section 18 with respect to information submitted under Item 2.02 or Item 7.01 of Form 8-K.  We are not incorporating by reference any information submitted under Item 2.02 or Item 7.01 of Form 8-K into any filing under the Securities Act or the Exchange Act or into this prospectus.  Any statement contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.
 
You may request copies of these filings, at no cost, by writing to or calling our Investor Relations department at:
 
ANTs software inc.
71 Stevenson Street, Suite 400
San Francisco, CA 94105
Telephone: (659) 930-0500

Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, Proxy Statements and amendments to reports filed or furnished pursuant to Sections 13(a) and 15 (d) of the Securities and Exchange Act are also available free of charge on our Investor Relations Web site at www.ants.com as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.  Additional information about the Company can also be found on our website at www.ants.com.

Additionally, the public may read and copy any materials filed with the SEC at the SEC's Public Reference Room at 100 F Street, NE, Washington, DC 20549.  The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.  The SEC also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC and can be found at www.sec.gov.
 
 
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the registrant pursuant to the foregoing provisions, the Company has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of Company’s legal counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether indemnification is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 
28

 
PART II – INFORMATION NOT REQUIRED IN PROSPECTUS
 
 
The following table sets forth the fees and expenses to be incurred in connection with the registration of the securities being registered hereby, all of which will be borne by us. Except for the SEC registration fee, all amounts are estimates.

Description
 
Amount
 
SEC Registration Fee
  $ 1,656  
Accounting fees and expenses
  $ 10,000  
Legal fees and expenses
  $ 15,000  
Miscellaneous expenses
  $ 3,344  
Total
  $ 30,000  


Section 102 of the Delaware General Corporation Law permits a corporation to eliminate the personal liability of its directors or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his or her duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Our Amended and Restated Certificate of Incorporation provides that no director shall be personally liable to us or our shareholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except to the extent that the Delaware General Corporation Law prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty.

Section 145 of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers as well as other employees and individuals against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed actions, suits or proceedings in which such person is made a party by reason of such person being or having been a director, officer, employee or agent to the Company.  The Delaware General Corporation Law provides that Section 145 is not exclusive of other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise.

As permitted by Section 145 of the General Corporation Law of Delaware, Article V(B) of the Registrant’s Amended and Restated Certificate of Incorporation, provides as follows:

“To the fullest extent not prohibited by law, the Corporation:  (i) shall indemnify any person who is made, or threatened to be made, a party to an action, suit or proceeding, whether civil, criminal, administrative, investigative, or otherwise (including an action, suit or proceeding by or in the right of the Corporation), by reason of the fact that the person is or was a director of the Corporation, and (ii) may indemnify any person who is made, or threatened to be made, a party to an action, suit or proceeding, whether civil, criminal, administrative, investigative, or otherwise (including an action, suit or proceeding by or in the right of the Corporation), by reason of the fact that the person is or was an officer, director, employee or agent of the Corporation, or a fiduciary (within the meaning of the Employee Retirement Income Security Act of 1974), with respect to any employee benefit plan of the Corporation, or serves or served at the request of the Corporation as a director, officer, employee or agent of, or as a fiduciary (as defined above) of an employee benefit plan of, another corporation, partnership, joint venture, trust or other enterprise.  This Certificate shall not be deemed exclusive of any other provision for the indemnification of directors, officers, employees, or agents that may be included in any statute, bylaw, agreement, resolution of shareholders or directors or otherwise, both as to action in any official capacity and action in any other capacity while holding office, or while an employee or agent of the Corporation.”

 
29

 
Section 102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability for any breach of the director’s duty of loyalty to the corporation or its stockholders, for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, for unlawful payments of dividends or unlawful stock repurchases, redemptions or other distributions or for any transaction from which the director derived an improper personal benefit.

As permitted by Section 102 of the General Corporation Law of Delaware, Article V(A) of the Registrant’s Amended and Restated Certificate of Incorporation, provides as follows:

“To the fullest extent that the Delaware General Corporation Law, as it exists on the date hereof or may hereafter be amended, permits the limitation or elimination of the liability of directors, a director of the Corporation shall not be liable to the Corporation or its stockholders for any monetary damages for conduct as a director.  Neither any amendment to or repeal of this Certificate or amendment to the Delaware General Corporations Law nor the adoption of any provision of this Certificate of Incorporation inconsistent with this Certificate shall adversely affect any right or protection of a director of the Corporation for or with respect to any acts or omissions of such director occurring prior to such amendment or repeal.”

The Registrant’s Amended and Restated Bylaws, provide in Article V, Section 6 for the indemnification of Registrant’s corporate agents as follows:

“The Corporation shall indemnify each of its agents against expenses, judgments, fines, settlements and other amounts, actually and reasonably incurred by such person by reason of such person’s having been made or having threatened to be made a party to a proceeding in accordance with the provisions of the Articles of Incorporation and Delaware General Corporation Law.  The Corporation shall advance the expenses reasonably expected to be incurred by such agent in defending any such proceeding upon receipt of the undertaking required by subdivision (f) of Title 8, Section 145 of Delaware law.  The terms “agent”, “proceeding” and “expenses” made in this Section 6 shall have the same meaning as such terms in the Delaware General Corporation Law.”

In addition to the above, the Registrant has entered into indemnification agreements with its directors and executive officers to indemnify the foregoing persons against any and all expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by each of them in connection with any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (including an action by or in the right of Corporation) to which the indemnified person is, was or at any time becomes a party, or is reasonably thought to be threatened to be made a party, by reason of the fact that the indemnified person is, was or at any time becomes a director, officer, employee or agent of the Registrant, or is or was serving or at any time serves at the request of the Registrant as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise.

Notwithstanding the foregoing, under the indemnification agreements between the Registrant and its directors and executive officers, no indemnity will be paid for any of the following:  (i) to the extent the aggregate of losses to be indemnified exceeds the sum of (A) such losses for which the director or officer is indemnified and (B) any settlement pursuant to any D & O Insurance purchased and maintained by the Registrant; (ii) in respect to remuneration paid to the director or officer if it shall be determined by a final judgment without right of appeal, or other final adjudication that such remuneration was in violation of law; (iii) on account of any suit in which judgment is rendered against the director or officer for an accounting of profits made from the purchase or sale by him of securities of the Registrant pursuant to the provisions of Section 16(b) of the Exchange Act or similar provisions of any federal, state or local statutory law; (iv) on account of the director’s or officer’s acts or omissions that involve intentional misconduct or a knowing and culpable violation of law; (v) on account of any proceeding (other than the enforcement of the indemnification agreement by the director or officer against the Registrant) initiated by the director or officer unless such proceeding was authorized by the uninterested directors of the Registrant; or (vi) if a final decision without right of appeal by a Court having jurisdiction in the matter shall determine that such indemnification is not lawful.

 
30

 
Additionally, no indemnity will be paid for any of the following:  (i) on account of acts or omissions that the director or officer believed or believes to be contrary to the best interests of the Registrant or its shareholders or that involve the absence of good faith on the part of the director or officer; (ii) with respect to any transaction from which the director or officer derived an improper personal benefit; (iii) on account of acts or omissions that show a reckless disregard for the director’s or officer’s duties to the Registrant or its shareholders in circumstances in which the director or officer was aware, or should have been aware, in the ordinary course of performing his duties, of a risk of serious injury to the Registrant or its shareholders; (iv) on account of acts or omissions that constitute an unexcused pattern of inattention that amounts to an abdication of the director’s or officer’s duties to the Registrant or its shareholders; (v) to the extent prohibited by Section 144 of the Delaware general Corporation Law, entitled “Interested Directors; Quorum;” (vi) in respect of any claim, issue or matter as to which the director or officer shall have been adjudged to be liable to the Registrant in the performance of his duties to the Registrant and its shareholders, unless and only to the extent that the court in which such proceeding is or was pending shall determine upon application that, in view of all the circumstances of the case, the director or officer is fairly and reasonably entitled to indemnity for expenses and then only to the extent that such court shall determine; (vii) of amounts paid in settling or otherwise disposing of a pending action without court approval; and (viii) of expenses incurred in defending a pending action which is settled or otherwise disposed of without court approval.

The indemnification provisions in the Amended and Restated Certificate of Incorporation, the Amended and Restated Bylaws and the indemnification agreements entered into between the Registrant and its directors and officers may be sufficiently broad to permit indemnification of the Registrant’s directors and officers for liabilities arising under the Securities Act.

 
Set forth below is information regarding securities issued by us within the past three years.  Also included is the consideration, if any, received by us for such securities and information relating to the section of the Securities Act, or rule of the SEC, under which exemption from registration was claimed.  No underwriters were involved in any such sales.

Private Placements; Equity Stock; Warrants

All purchasers in the private placements qualify as accredited investors as such term is defined in Rule 501 under the Securities Act.  The Common Stock issued by the Registrant to the investors has not been registered under the Securities Act.  The offer and sale of these shares was made in connection with a private placement and is exempt from the registration requirements of the Securities Act pursuant to Section 4(2) thereof and Rule 506 of Regulation D promulgated thereunder and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

As previously noted, on March 22, 2010, the Registrant engaged in the Stock Purchase Agreement in which 1,500,000 shares of the Registrant’s then-restricted common stock, which shall be registered pursuant to this prospectus, were sold to Fletcher at a per share price of $1.00.  The Registrant received an aggregate of $1,500,000.  In addition to each share of common stock sold in this transaction, Fletcher received a warrant to purchase up to $10,000,000 of additional shares of the Registrant’s common stock, which shall be registered pursuant to this prospectus, at an initial purchase price of $0.903 per share, subject to adjustment under the terms and conditions of the warrant and Stock Purchase Agreement between the Company and Fletcher, and such warrant to expire March 17, 2019 unless replaced by a subsequent warrant if one is issued pursuant to the terms and conditions of the Stock Purchase Agreement.

 
31

 
Between December 12, 2009 and February 26, 2010, the Registrant engaged in a private placement transaction in which 3,715,321 shares of the Registrant’s restricted Common Stock were sold at a per share price of $0.40.  The Registrant received an aggregate of $1,486,128.  In addition to each share of Common Stock sold in the above transaction, each purchaser also received a warrant to purchase one share of the Registrant’s restricted Common Stock at $0.50 per share, such warrants to expire one year from purchase of the initial Common Stock shares.
 
On November 6, 2009, the Registrant granted 200,000 shares of restricted Common Stock, subject to vesting, valued at $0.60 per share to a consultant as consideration for investor relations services rendered.  As of March 31, 2010, 100,000 shares had vested.

Between August 31, 2009 and October 31, 2009, the Registrant engaged in a private placement transaction in which 6,330,082 of shares of the Registrant’s restricted Common Stock were sold at a per share price of $0.35.  The Registrant received an aggregate of $2,215,529.  In addition to each share of Common Stock sold in the above transaction, each purchaser also received a warrant to purchase one share of the Registrant’s restricted Common Stock at $0.40 per share, such warrants to expire one year from purchase of the initial Common Stock shares.
 
On October 21, 2009 the Company issued 57,548 shares of restricted Common Stock valued at $0.71 per share as interest on a convertible promissory note.

On September 18, 2009, the Registrant entered into an agreement with Constantin Zdarsky, an existing investor and warrant holder, in which his 3,002,150 common stock warrants were cancelled and the Registrant granted a new warrant to purchase up to 1,050,752 shares of the Registrant’s Series A Convertible Preferred Stock at a per share exercise price of $1.00 and exercisable through April 30, 2010 (the “Preferred Stock Warrant”).  The Registrant also granted a new common stock warrant to purchase up to 7,502,151 shares of the Registrant’s Common Stock at a per share price of $0.40 and exercisable through January 1, 2014.  Pursuant to the agreement, Mr. Zdarsky committed to serially exercise his purchase right under the Preferred Stock Warrant with respect to all 1,050,752 shares of Series A Convertible Preferred Stock as follows: 250,000 warrants by September 22, 2009, 250,000 warrants by December 31, 2009, 250,000 warrants by February 28, 2010 and 300,752 warrants by April 30, 2010.

From July 2 through July 4, 2009, the Registrant entered into agreements with certain promissory note holders, in which their notes were converted into Series A Convertible Preferred Stock as of July 1, 2009.  Pursuant to the agreements, the total aggregate amount owed under the notes totaling $8,503,226, plus accrued and unpaid interest through the date of the conversion totaling $425,161 was converted into 8,928,387 shares of Series A Convertible Preferred Stock at a price of $1.00 per share.  In addition to the note conversion, three outstanding warrants dated November 15, 2005, October 18, 2007 and December 18, 2007, for the purchase of an aggregate amount of 3,002,150 shares of Common Stock at a price of $0.80 per share, were extended for one year.
 
During the quarter ended June 30, 2009, the Registrant received $339,000 from the sale of 847,500 shares of the Company’s restricted Common Stock to accredited investors at a price of $0.40 per share.

During the quarter ended June 30, 2009, the Registrant received $115,000 from the sale of 1% Convertible Promissory Notes to accredited investors.  These notes were immediately converted into 287,500 shares of the Company’s restricted Common Stock at $0.40 per share. In conjunction with the sale of promissory notes, the Company issued 287,500 Common Stock warrants exercisable at $0.47 per share and exercisable for three years.

During the quarter ended June 30, 2009, as consideration for services rendered as placement agent, the Registrant issued 23,850 shares of our restricted Common Stock valued at $0.56 per share.
 
On or about May 19, 2009, the Registrant and David Brown, Brown Development ACC and MH Investments, the holders of $750,000 in convertible promissory notes (the “Notes”) agreed to amend the Notes and convert the principal face value of the Notes into Common Stock of the Registrant.  David Brown, Brown Development ACC and MH Investments, the holders of an aggregate of $625,000 in Notes agreed to convert the principal amount of those Notes into Common Stock of the Registrant at a conversion price of forty cents ($0.40) per share and MH Investments, the holder of a $125,000 Note, agreed to convert the principal amount of that Note into Common Stock of the Registrant at a conversion price of sixty cents ($0.60) per share.  The Registrant issued 1,770,833 shares in connection with the conversions.  The note holders agreed to forgive all interest accrued from January 1, 2009 through the date of conversion and the Notes were terminated.

Between March 4, 2008 and May 19, 2008, the Registrant engaged in a private placement transaction in which an aggregate of 12,491,667 shares of the Registrant’s restricted Common Stock was sold for a per share price of sixty cents ($0.60).  The Registrant received an aggregate of $7,495,000.  In connection with this private placement the Registrant paid $328,100 in cash commissions and issued 497,121 shares of the Registrant’s Common Stock to a placement agent.
 
On May 1, 2009, the Registrant granted 200,000 shares of restricted Common Stock, subject to vesting, valued at $0.46 per share and 300,000 Common Stock warrants, subject to vesting, exercisable at $0.01 per share for three years to a consultant for investor relations services.  As of March 31, 2010, 150,000 shares of Common Stock underlying the grant had vested and 225,000 shares of Common Stock underlying the warrants had vested.
 
On  March  31,  2008,  the  Registrant  received  $1,041,000  from  accredited investors,  for the sale of 1,735,000 shares of the Registrant’s restricted Common Stock, at a price of $0.60 per share.  The Registrant paid a placement agent a cash commission of $104,100 and issued 157,727 shares in connection with this private placement.

 
32

 
On December 18, 2007 (the “Issuance Date”), the Registrant received an aggregate of $1,003,226 from an accredited investor, for the sale of a convertible promissory note (the “Note”) and warrant (the “Warrant”), covering, in aggregate, 1,337,634 shares of the Registrant’s restricted Common Stock.  The Note bears interest at the rate of 10% per annum, simple interest, matures 36 months from the Issuance Date, and is convertible into 668,817 shares of the Company’s restricted Common Stock, at the election of the holder, at a per share price of $1.50.  The Note is prepayable without penalty in the event that the closing per share bid price for shares of the Registrant’s restricted Common Stock equals or exceeds $4.00 for 10 consecutive trading days and the Company provides 20 trading days advance notice of such intention to prepay.  The Warrant has a term of 36 months, may be exercised beginning on the Issuance Date and may be exercised into 668,817 shares of the Registrant’s restricted Common Stock at a per share exercise price of $3.25.

 
 

Exhibit Number
 
Description
     
3.1(1)
 
Amended and Restated Certificate of Incorporation of the Registrant.
3.2(2)   Certificate of Designation of Rights, Preferences, Privileges and Restrictions of Series A Preferred Stock of ANTs software inc.
3.3(3)
 
Amended and Restated Bylaws of the Registrant.
4.1(4)
 
Instrument Defining Rights of Security Holders.
5.1
 
Opinion of The Corporate Law Group.*
10.1
 
Stock Purchase Agreement between Registrant and Selling Shareholder.
10.2
 
Warrant to Purchase Shares of Registrant’s Common Stock.
10.3(5)
 
Form of Indemnification Agreement signed with officers and directors of the Company.
11.1(6)
 
Statement Regarding Computation of Per Share Earnings.
23.1
 
Consent of Weiser LLP, Independent Registered Public Accounting Firm.
23.2
 
Consent of The Corporate Law Group (contained in Exhibit 5.1).
24.1
 
Power of Attorney (see signature page of this Registration Statement).
 
*
To be filed by amendment
 
(1)
Incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form S-8, filed with the SEC on September 8, 2008.
 
(2)
Incorporated by reference to Exhibit 3(i) to the Registrant’s Current Report on Form 8-K filed with the SEC on September 23, 2009.
 
(3)
Incorporated by reference to Exhibit 3.2 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2007, filed with the SEC on March 17, 2008.
 
(4)
The description of Registrant’s common stock contained in Registrant’s Form 10SB12G filed with the SEC on September 14, 1999 including any amendment or report filed for the purpose of updating such description.

(5)
Incorporated by reference to Exhibit 10.5 to the Registrant’s Annual Report on Form 10-KSB for the year ended December 31, 2000, filed with the SEC on March 22, 2001.
   
(6)
Incorporated by reference to the financial statements included with Registrant’s Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 31, 2010.
 
 
33

 
 
 
(a)           The undersigned registrant hereby undertakes:
 
(1)           To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
 
(i)           To include any prospectus required by section 10(a)(3) of the Securities Act;
 
(ii)           To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.  Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement;
 
(iii)           To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.
 
Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement.
 
(2)           That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
 
(3)           To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(4)           That, for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of the securities: The Registrant undertakes that in a primary offering of securities of the Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
 
(i)           Any preliminary prospectus or prospectus of the Registrant relating to the offering required to be filed pursuant to Rule 424;
 
(ii)           Any free writing prospectus relating to the offering prepared by or on behalf of the Registrant or used or referred to by the undersigned registrant;
 
(iii)           The portion of any other free writing prospectus relating to the offering containing material information about the Registrant or its securities provided by or on behalf of the Registrant; and
 
(iv)           Any other communication that is an offer in the offering made by the Registrant to the purchaser.

(b)           The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 
34

 
(c)           The Registrant hereby undertakes to deliver or cause to be delivered with the prospectus, to each person to whom the prospectus is sent or given, the latest annual report to security holders that is incorporated by reference in the prospectus and furnished pursuant to and meeting the requirements of Rule 14a-3 or 14c-3 under the Exchange Act; and, where interim financial information required to be presented by Article 3 of Regulation S-X is not set forth in the prospectus, to deliver, or cause to be delivered to each person to whom the prospectus is sent or given, the latest quarterly report that is specifically incorporated by reference in the prospectus to provide such interim financial information.

(d)           The undersigned Registrant hereby undertakes that:

(1)           For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

 (2)           For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 
35

 


Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Alpharetta, State of Georgia, on April 23, 2010.
 
  ANTs software inc.
     
 
By
/s/ Joseph Kozak
   
Joseph Kozak,
   
Chairman, Chief Executive Officer and President
 
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
 
 
By
/s/ Joseph Kozak
   
Joseph Kozak,
   
Chief Executive Officer and President
     
 
Date
April 23, 2010
     
     
 
By
/s/ David Buckel
   
David Buckel, Secretary and
   
Chief Financial Officer
     
 
Date
April 23, 2010
 
 
 
DIRECTORS
     
 
By
/s/ Joseph Kozak
   
Joseph Kozak, Chairman, Chief Executive Officer
   
and President
     
 
Date
April 23, 2010
     
     
 
By
/s/ Craig L. Campbell
   
Craig Campbell, Director
     
 
Date
April 23, 2010
     
     
 
By
/s/ John R. Gaulding
   
John R. Gaulding, Director
     
 
Date
April 23, 2010
     
     
 
By
/s/ Robert T. Jett
   
Robert T. Jett, Director
     
 
Date
April 23, 2010
     
 
 
 
36

 
 
     
 
By
/s/ Ari Kaplan
   
Ari Kaplan, Director
     
 
Date
April 23, 2010
     
     
 
By
/s/ Robert H. Kite
   
Robert H. Kite, Director
     
 
Date
April 23, 2010
     
     
 
By
/s/ Francis K. Ruotolo
   
Francis K. Ruotolo, Director
     
 
Date
April 23, 2010

 
 
POWER OF ATTORNEY
 
We, the undersigned officers and directors of ANTs software inc., hereby severally constitute and appoint Joseph Kozak and David Buckel, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him or her and in his or her name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement (or any other Registration Statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof.
 
 Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons on this 23rd day of April, 2010 in the capacities indicated.
 
Signature
  
Title
   
/s/ Joseph M. Kozak
Joseph M. Kozak
  
Chairman of the Board, Chief Executive Officer, President and Director (principal executive officer)
   
/s/ David Buckel
David Buckel
  
Chief Financial Officer and Secretary
(principal financial officer, principal accounting officer)
   
/s/ Francis K. Ruotolo
Francis K. Ruotolo
  
Director
   
/s/ John R. Gaulding
John R. Gaulding
  
Director
   
/s/ Robert H. Kite
Robert H. Kite
  
Director
   
/s/ Craig Campbell
Craig Campbell
  
Director
   
/s/ Ari Kaplan
Ari Kaplan
  
Director
   
/s/ Robert T. Jett
Robert T. Jett
  
Director

 
37